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Solid-phase extraction (SPE) is a sample preparation method used as a means of 
separation, concentration, and purification for analysis of complex unknown samples 
in the analytical field. Recently, there have been efforts to increase binding affinity, 
sensitivity, and selectivity through biomimetic surface engineering. In the analysis 
of complex biological samples, like blood and cells, physical and chemical 
interactions between the solid-phase surface and target species are crucial. These 
interactions can be divided into those in which the target analyte directly interacts 
with the solid surface and those in which the secreted substance is observed upon the 
introduction of target analyte, including cells, to the surface. This dissertation 
 
ii 
describes (i) bio-inspired surface modifications for enhanced analyte-solid surface 
interactions and (ii) the purification of synaptic cell adhesion proteins for induced 
artificial synapses and bioanalysis. 
 
Part I. Analyte-solid surface interaction: virus-decorated magnetic gold 
microshells with biomimetic architectures for enhanced immunoassays 
 
Filamentous phage virus has similar structural dimensions to many cellular 
threadlike structures that enhance the cellular functions. The aim of this study was 
to combine the virus and microshells to resemble biological systems, thereby 
harnessing the enhancement factors originating from the unique morphology. We 
implemented gold layer on a microshell to form a self-assembled monolayer that 
help with chemical modifications using streptavidin and protection from non-
specific adsorptions. Phage virions that carry biotins within their tails were prepared 
for directional binding of the virions to streptavidin-modified gold microshells. We 
confirmed the augmented yield of antibody loading on virus-modified gold 
microshells because of the increased surface to volume ratio. Indeed, the sensitivity 
has increased up to nine-fold for the detection of cardiac marker proteins. This work 
demonstrates the feasibility of merging viruses with non-biological substrates to 





Part II. Cell-solid surface interaction: purified synaptic cell adhesion 
molecules for induced artificial synapse 
 
Conventional neural interfaces solely depend upon passive physical contact 
between nerve cells and their non-biological counterparts. Nerve cells in the brain, 
however, communicate via synapses of which spatiotemporal specificity is 
exquisitely regulated. Here, we report a newly engineered postsynaptic cell adhesion 
molecules (CAMs) that are fluorescent and biotinylated to facilitate its purification, 
quantification, tracking, and immobilization on inorganic substrates. The 
independence of synaptic CAMs on the lipid membranes, originating from the 
orientation-controlled immobilization, extends versatility of the protein to fit in 
artificial synapse formation between neurons and various types of inorganic solid 
substrates. Moreover, this method will be used as the basis for studying the 
interaction between the cell and solid surface. 
 
Keywords: gold microshell, suspension array, non-specific binding, virus, artificial 
synapse, neuroligin, synaptic cell adhesion molecules 
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regardless of the position of the fluorescence protein. Y-NL1-G was probed by anti-
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1. Background and Overview 
 
1.1. Immunoassay 
The first immunoassay was developed by Landsteiner in 1954, who detected small 
molecules called “haptens” using antibodies [1]. In 1971, E. Engvall and P. Perlmann 
introduced enzyme-linked immunoassay [2], which is now known as the 
representative enzyme-linked immune-sorbent assay (ELISA); it is used to observe 
color changes using antibodies. Such immunoassays are widely used as quantitative 
methods for detecting supramolecules (e.g., cells, proteins, and polypeptides) and 
small molecules (lipids, hormones, chemicals, etc.) in various fields of molecular 
biology and environmental science. Color changes of substrates such as 
tetramethylbenzidine (TMB) and p-nitrophenyl phosphate (p-NPP) following 
reaction with antibodies were observed in traditional ELISA, but recently, ELISA-
like technologies that do not use enzymes, but use a new reporter that generates 
various signals, have been widely adopted [3-10]. 
Immunoassays are categorized into optical and non-optical methods 
(electrochemical, mass sensitive, calorimetric) depending on the transducing 
mechanism. Optical immunoassay can be classified into the following 6 types: 1. 
UV/VIS spectroscopy, which measures the optical or electronic properties of a 
material, such as absorption, transmission, and reflectivity; 2. fluorescence, which 
measures the shift in the wavelength of the fluorophore, time dependence of 
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fluorescence emission, and energy transfer phenomena; 3. surface plasmon 
resonance, which measures the changes in wavelength, intensity, and the phase or 
angle of incidence; 4. chemiluminescence, which measures characteristic light from 
a reaction product prepared by oxidation of a luminol reactant; 5. Raman 
spectroscopy, which measures vibrational energy states; and 6. Interferometry, 
which measure the changes in the evanescent field. The optical immunoassay has the 
advantages of high sensitivity and high speed and benefit from developing 
infrastructure. Especially, as the fluorescence immunoassay method does not require 
additional substrate (TMB, p-NPP, luminol) is being widely used. The fluorescence 
immunoassay can be carried out by one of two methods: by conjugating the 
fluorophore or the quantum dot to the antibody. Of these two, the fluorophore-based 
method is widely used. 
The representative advantage of immunoassay over other binding assays is its 
low detection limit and high analyte selectivity. On the other hand, its representative 
disadvantages are that it is greatly influenced by antibody activity and its cross 
reactivity with the structural analogs of the target analyte [11]. As indicated by Prof. 
B. M. Spiegelman [12] and Prof. A. J. Wagers [13], immunoassays using antibodies 
have become controversial, so much so that an article named 'Blame it on the 
antibodies' was published in Nature 2015. Although errors due to incorrect molecular 
recognition may arise with use of antibodies in immunoassays, no other substitute 
binding has been developed, and the immunoassay remains one of the preferred 
methods for biological sample analysis [14]. 
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1.2. Planar array and suspension array 
The quality and average expectancy of human life have increased with rapid 
advancements of modern science. In terms of disease diagnosis, specific test items 
have also increased with the advancement of science and technology. For example, 
there are over 200 test items (Table 1), including chemicals, DNA, lipid protein, and 
cells in a blood test [15], and early diagnosis is critical for disease 
prevention/treatment [16, 17].  
 
Table 1. Sorted by category of blood analysis 
 category # of test 
1 Ions and trace metals 17 
2 Acid-base and blood gases 9 
3 Liver function 9 
4 Cardiac marker 9 
5 Lipids 6 
6 Tumour markers 9 
7 Endocrinology 29 
8 Vitamins 8 
9 Toxins 2 
10 Hematology 31 
11 Immunology 25 
12 Other enzymes and proteins 7 
13 Other electrolytes and metabolites 12 
 
 
Rapid, accurate, low-cost, and efficient detection and quantification of various 
disease markers from a limited amount of samples is the hot topic of interest in 
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analytical chemistry. The conventional immunoassay format of ELISA requires 
about 500 ng of capture antibody and 50~100 µL of a sample to analyze one 
specimen. As a result, an array type binding assay technology has been developed as 
a miniaturized, parallel binding assay for multiplexed detection [18]. The first 
multiplexed immunoassay was developed by L. G. Feinberg in 1961 for microspot 
test of antibody-antigen reaction in the thin agar films on the cover glass [19]. Since 
then, various attempts have been made, but the main approach can be divided into 2 
general methods: the use of 2D planar micro arrays or 3D suspension array. 
A 2D planar array is an assay that captures molecules immobilized in 
microspots (diameter < 250 µm), with several thousand spots exist per square 
centimeter [20]. The individual microspots are located hundreds of micrometers 
apart to prevent mutual contamination, and may immobilize different capture 
molecules. DNA chip and Protein chip are examples of 2D planar arrays, often 
referred to as a planar array or a microarray [21]. The protocol of a 2D planar array 
is similar to that of conventional ELISA, and generally scans fluorescence or 
chemiluminescent signals. For multiplexed detection, the different capture 
molecules must be located at nearby spots and the array needs to remember the 
immobilized capture molecule at each spot. When the X and Y locations are 
memorized in a 2D planar array for multiplexed detection, it is easier to remember 
the locations of the capture molecules, which is a comparatively easier barcoding 
method than 3D suspension array. 
A 3D suspension array is an analytic system that suspends a few micrometer-
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sized microspheres (particles or beads) of the immobilized capture molecules in a 
solution, and reacts them with an unknown sample to detect the signals from these 
particles. The suspension array has the following advantages over planar array. First, 
the total assay time (TAT) is shorter and a smaller sample volume is required. As the 
Micrometer sized particles have fast diffusion and smaller steric hindrance with their 
high surface to volume ratio, compulsory-mixed by external force is possible. 
Furthermore, a planar array must set adjacent spots apart by a fixed distance to 
prevent their cross contamination, creating a dead surface that consequently 
increases the area contacted by the sample solution. Therefore, the suspension array 
requires shorter total analysis time compared to the planar array, with a smaller 
sample volume. Second, it has greater sensing flexibility with the different capture 
molecules that can be mix-and-matched at different combinational at will. Third, the 
suspension array can replicate each target molecule from hundreds to thousands in 
the single experiment, offering greater reproducibility and high precision 
measurements. Fourth, it is cost-effective because of the reduced TAT and improved 
reproducibility and precision by performing only one experiment [20]. Unlike a 2D 
planar array, a 3D suspension array has suspended micrometer-sized particles that 
move while in solution, requiring barcoding for individual particles. The most widely 
used barcoding method is the optical one, which uses an organic dye [22], quantum 
dots [23], IR [24], or a Raman probe [25]. Chemical [26], graphical [27], electronic 
[28], and physical methods [29] are also used. 
A planar array obtains signals by scanning, but a suspension array obtains 
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information using flow cytometry. Flow cytometry hydrodynamically focuses the 
suspended particles in a solution and passes a beam of light (usually laser light) of 
single wavelength through the suspension for the analysis. Coulter counter and 
fluorescence-activated cell sorter (FACS) are representative analytical methods of 
flow cytometry. Since the first report of flow cytometry in the 1960s, it has been 
used in a variety of areas, and has become an essential technique in the diagnosis of 
health disorders [30]. A conventional Coulter counter or FACS has the disadvantages 
of being expensive and very large. To compensate for these disadvantages, 
microfluidic chip based flow cytometry has been introduced. J. M. Ramsey 
distinguished 1- and 2 μm particles through electrokinetic focusing in a microchip 
and reported a throughput of 34 particles [31]. T. D. Chung et al. distinguished white 
blood cells and red blood cells using a microfluidic chip and direct current (DC) 
impedance [32], and in 2010, developed a microflow-cytometry system that could 
simultaneously detect particle size by DC impedance and fluorescence by laser [33]. 
Recently, a mixed planar array system has been reported, which can lithographically 
build a wall to immobilize the particles while scanning to detect signals [34]. 
 
1.3. Microspheres 
Polymer particles, such as poly(methyl methacrylate) (PMMA), polystyrene (PS), or 
silica particles of 1~100 µm (mostly 2~15 µm) are generally used in 3D suspension 
array systems. Polymer or silica particles are separated by centrifugation, but 
magnetic particles, which encapsulate magnetic pigments such as iron oxide and 
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nickel particles or whose surfaces have been introduced with a magnetic pigment, 
are widely used. Presently, microspheres are moving beyond the academic field 
(Figure 1) of experimentation and are being widely used commercially. These types 
of microspheres are being widely used in clinical diagnostics, molecular 
assays/cellular assays (drug targeting, cell isolation and purification, nucleic acid or 




Figure 1. Number of papers published in each year between 1985 and 2014 in which 
terms microsphere and/or microspheres were used, according to the ISI Web of 





















































Many companies sell microspheres or microsphere-related products. For 
commercially available microspheres, certain beads builders sell naked beads (Table 
2); however, most of the time, they sell surface-functionalized or modified beads, 
while also providing experimentation services (Table 3) [36].  
 
Table 2. List of commercialized beads builders. 
Company Products Location 
Dynal Biotech Inc.  Thermo Polymer Norway 
Merck Estabor  Millipore Polymer/Silica France 
Seradyn Inc. Thermo Polymer USA 
Bnag’s Lab. Polymer/Silica USA 
Luminex Corp. Polymer USA 
Immunico Corp.  
Johnson&Johnson/Veridex 
Polymer/Silica USA 
Spherotech Inc. Polymer/Silica USA 
Advanced Magnetics Inc. Polymer U.K. 
CPG Inc.  Millipore Polymer USA 
Promega Polymer USA 
Ferrofluidics Corp. Polymer USA 
FeRx Inc. Polymer USA 
Miltenyi Biotec Polymer Germany 
PolyMicrospheres Inc. Polymer USA 
Chemicell Polymer/Silica Germany 
 
 
Bangs laboratories, Inc., established in 1988, provides 1–25 μm PS, PMMA, or 
SiO2 particles whose surface have been aminated or caboxylated, or decorated with 
a certain antibody or protein [37]. Dynabeads, widely known as Thermo Fisher 
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Scientific Company, sells various products such as iron oxide type magnetism 
introduced 1, 2.8, 4.5 μm sized PS particles conjugated with glycidyl ether and 
having proteins on their surfaces [38]. The US microspheres-Nanospheres Company 
sells sub-micrometer sized particles of gold, silver, aluminum oxide, titanium oxide, 
silicon oxide and 1–100 μm particles of PS, PMMA, and SiO2, as well as surface-
functionalized products [39]. 
 
Table 3. List of commercialized beads products and services. 
Company Products & Services Location 
Marligen Biosciences Transcription Factors Maryland, USA 
Panomics mRNA, RNAi, Immunoassays California, USA 
Radix BioSolutions Ltd. DNA Hybridization, Immunoassays Texas, USA 
Applied Cytometry Systems Software & Assay Development California, USA 
Bio-Rad Life Science 
Bio-Plex: Instruments, Cytokines, 
Isotyping, etc. 
California, USA 
Cayman Chemical Company 






Eva Technologies Corp. Autoimmunity, Cancer, etc. Alberta, Canada 
Exiqen Gene Expression Denmark 





Allergy Virginia, USA 
Invitrogen 
Cytokines, Signal Transduction, 
Neuroscience, etc. 
California, USA 
Marligen Biosciences, Inc. Genotyping & mRNA Maryland, USA 
Millipore Corp. 
Cytokines, Apoptosis, Cardiac, 
Endocrine, etc. 
Missouri, USA 
MiraiBio Equipment, Software & Materials California, USA 
Novagen Cellular Signaling & Cancer Wisconsin, USA 
Panomics Cellular Signaling, Cytokines, etc. California, USA 









R&D Systems, Inc. Cytokines, MMP’s, etc. Minnesota, USA 
Rules Based Medicine Assay Services Texas, USA 
Wageningen University and 
Research Center 
Plant pathogenic virus The Netherlands 
Abbott Molecular Inc. FISH Illinois, USA 
Asuragen 
Signature, Genetic Testing, 
Oncology 
Texas, USA 
BMD Autoimmune & Infectious Disease France 
Bio-Rad Diagnostics Autoimmune, etc. California, USA 
Celera Diagnostics Infectious Disease &Cystic Fibrosis California, USA 
MiraiBio Equipment, Software & Materials California, USA 
EraGen Biosciences Genetic Analysis Wisconsin, USA 
Fisher Healthcare Prima Texas, USA 
Focus Diagnostics Assay Services California, USA 
INOVA Diagnostics, Inc. Autoimmune Disease California, USA 
ImmuneTech Allergy California, USA 
InnoGenetics NV Neurodegeneration Belgium 
Inverness Medical 
Professional Diagnostics 
Autoimmune Disease New Jersey, USA 
MICROBIONIX GmbH 




Infectious disease, Inflammation, 
Coagulation, etc. 
Germany 
One Lambda, Inc. HTA Testing California, USA 
Tepnel Lifecodes HLA Testing 
Connecticut, 
USA 
Zeus Scientific, Inc. Autoimmune Disease New Jersey, USA 
 
 
The representative company that offers suspension arrays is Luminex Corp., 
established in 1996. They offer not only microspheres but also provide integrated 
support from signal readout devices to experimental services. Various chemical 
functional groups and oligomer or protein can be conjugated to a 5.6 μm size 
polystyrene particle, and 6.5 μm PS particles are used as magnetic microspheres [40]. 
Currently, 500-plex analysis is possible by swelling the polymer microspheres in an 
organic solvent and allowing two organic dyes of different proportions to enter the 
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microspheres, followed by shrinking them in an aqueous solution. Data can be 
acquired by flow cytometry, using the non-overlapping fluorophore wave as the 
target signal, and by barcoding and passing the microspheres through a fixed laser 
pathway. Like Luminex, Affymetrix also offers services related to microspheres that 
allow 100-plexed detection with an internal dye and 4–5 μm sized PS particles as the 
microspheres [41]. Miltenyi Biotec company offers 2, 3 µm microspheres, reagents; 
equipment; and total analysis service for flow cytometry and cell stimulation as a 
Magnetic Activated Cell Sorting (MACS) technology [42]. The Korean company 
Bioneer sells 1–5 μm SiO2-based magnetic microspheres with various surface 
modifications [43]. 
In 2007, T. Nagaoka et al. made gold-coated microspheres on polystyrene and 
reported their applications. They attached gold nanoparticles to 6 µm polystyrene 
particles and plated them by electroless plating to form a gold layer, introducing 
various metal layers, such as nickel, silver and copper, on the polymers for 
application in electronic devices [44]. Furthermore, in 2009, they introduced a gold 
layer on plastic particles using a binder, describing its potential use as an anisotropic 
conductive film (ACF) [45]. M. E. Meyerhoff et al. reported the first instance of 
using magnetic gold microspheres for immunoassay in 2006. They introduced gold 
to 4.5 µm magnetic polystyrene microspheres through electroless plating, and 
covalently attached antibody fragments to a tosyl-activated surface; the absorbance 
signal was detected using alkaline phosphatase and p-NPP [46]. At the same time, 
M. Liu et al. proposed a fluorescence signal analysis system by attaching antibodies 
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after forming a gold layer on 100 μm PS particles [47]. In 2011, an immune-device 
system integrating gold microspheres with immobilized protein using self-assembled 
monolayers, microfluidic chip, and dielectrophoresis was reported [48]. Commercial 
gold microspheres can be purchased from the SEKISUI chemical corp. and the 
Nomadien corp. SEKISUI gold microspheres were developed for electric contact, 
and contain nickel inside with the surface gold layer [49]. Nomadien corp. 
introduced magnetism and a layer of gold on 2–15 μm polymer microspheres, and 
showed their potential use in detecting various biological molecules [50-54]. 
 
1.4 Viruses 
Virus, a contagious particle of size less than a few hundred micrometers, replicates 
only inside the living cells of other organisms, and can be categorized into 
bacteriophages (shortened to phages), plant viruses, and animal viruses depending 
on the host. Early virus-related research was conducted in the fields of molecular and 
cell biology in the broad areas of life sciences and medicine. Recently, viruses have 
been used as chemical and biological sensors in material science and nanotechnology. 
Phages, which are used widely in sensing applications, have the following 
advantages. First is the well-established phage display technology. Phage display is 
a technique that selects the high-binding-affinity sequence by amplifying only the 
target-specific phage from a randomly sequenced phage library [55]. Second, they 
show high sensitivity and selectivity through target-specific recognition, an inherent 
virus function. Third, they exhibit multivalent interactions. A virus is composed of 
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several domain proteins, each domain having about 3000 copies. Therefore, a strong 
multivalence can be obtained if a target domain is given functionality [56, 57]. 
Fourth, they can be mass-produced in a cost-efficient manner in the host bacterial 
cell. Fifth, they have good chemical and thermal stability, allowing them to survive 
in acidic, basic, or non-aqueous media, and at temperatures up to 180 °C. Sixth, they 
can be used as a template for self-assembly of uniform size and shape with a 
nucleation site [58]. 
Phages can be categorized into lytic phages, such as T4 and MS2 phages, which 
replicate in a bacterial cell and leave the host cell after killing it, and non-lytic phages, 
such as M13 and fd phages, which leave the host cell without killing it. The T4 
bacteriophage, which is frequently shown in literature as having a spaceship-shaped 
icosahedral head and tail, has an inner diameter of 55 nm, tail length of 28.5 nm, and 
diameter of 19 nm. The MS2 phage, which looks like a nanosphere, has a diameter 
of 23–27 nm. Fd and M13 phages are nanofiber-shaped with a ~6 nm diameter and 
~1 μm length. Filamentous M13 and fd phages have been the most-preferred 
genetically modified phages since G. P. Smith first introduced the phage display 






Figure 2. Structure of filamentous phage (M13 or fd) and the genetically engineered 
version. The phage DNA is encased in a capside made of four minor coat proteins 
(pIII, pIX, pVI, and pVII) located at one of the two distal ends of the phage and one 
major coat protein (pVIII), several thousand copies of which constitute the side wall 
of the phage. The landscape phaeg library was pioneered by V. A. Petrenko and G. 
P. Smith (adapted from reference [66]). 
 
Of the 5 types of structural proteins that surround the internal single-strand 
DNA of the phages, genetic engineering techniques for the pIII and pVIII proteins 
have been reported most frequently, and two or more proteins can be genetically 
engineered simultaneously (Figure 2). For example, foreign peptides or proteins can 
be expressed in a certain structural protein by inserting the desired DNA sequence 
 
17 
in the gene of a phage vector. The yield of the structural protein with multiple copies 
is determined by the size and folding level of the expressed peptide; in general, a 
small peptide gives better expression than a large peptide. 
As the filamentous phages are themselves nanoparticles, much attention has 
been paid not only for their sensing applications in terms of function and shape, but 
also as templates for nanostructure synthesis. They have been used as chemical and 
biological sensors [61] in a form that integrates the inherent target-recognition 
function of phages with the conventional methods of quartz crystal microbalance 
[62-64], ELISA [65-67], and optical [68, 69] and electrochemical methods [70, 71]. 
To use phages as a template to introduce metals or metal oxides, a nucleation site or 
affinity is needed; different combinations have been reported using phage display 
(PD) and cell-surface display (CSD) [72]. A. M. Belcher et al. at Massachusetts 
Institute of Technology conduct active research on the application of phages as a 
template. They reported the potential use of phage-templated nanowires as electrodes 
for lithium-ion batteries in their representative study published in Science in 2006 
[73], with the nanowires made by expressing cobalt- and gold-nucleating motifs on 
phage body. J. N. Cha et al. detected surface-enhanced Raman spectroscopy signals 
after binding DNA-Raman-active nanoparticles to phages and loading the phages on 
silica microbeads [74]. K. T. Nam et al. successfully detected prostate-specific 
antigens using virus-probes, which were made by expressing the gold-binding 
peptide sequence on the phage body, integrating gold nanocubes, and immobilizing 
them on magnetic microbeads [75]. 
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1.5 Purpose of this work 
The major purpose of the current research was to develop a biocompatible and bio-
inspired biosensor with high potential to be used for the improved analyte-solid 
surface interactions. In this work, we will focus on demonstrating the feasibility of 
our phage-decorated three-dimensional suspension array system using cardiac 
marker proteins, cardiac troponin I (cTnI) and myoglobin. While many assay 
systems based on microbeads lack quantitative mode of action, our virus-gold 


















Recent outbreak of virus-based hybrid materials has enabled realization of highly 
selective and sensitive biosensors [58]. The benefits of the merger between virions 
and biosensing materials intuitively originate from the virion’s capability of 
molecular recognition [76-80] and innate physical properties that stem from the 
phenotypic morphologies [81-88]. However, despite the functional advances in 
biosensors using virus hybrids, the detection systems largely remain in two-
dimensional planar platforms, requiring relatively large sample volumes and greater 
time for analysis [58]. 
In this work, we demonstrate enhanced detection of protein biomarkers using 
gold-layered magnetic microspheres on which viral filaments are tethered in 
orientation-controlled manner. The magnetic gold microspheres, like many other 
typical microspheres, are compatible with flow cytometers, fluorescence activated 
cell sorting (FACS) systems, and conventional fluorescence microscopes, requiring 
minute sample volumes, and allowing statistical analysis that raises credibility [89]. 
Importantly, in contrast to nanoparticles, the gold microspheres are eligible for the 
detection of small molecule biomarkers in serum.  
In biosensor development for immunoassays, preventing non-specific 
adsorption while providing high antibody loading is of primary importance. Since 
we had been experiencing a heavy non-specific binding to typical polymer beads 
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when using blood or serum samples, we envisioned that covering the porous and 
sticky surfaces of the polymer beads with gold and thiol self-assembled monolayers 
(SAMs) should resolve the adsorption problem. The SAM molecules, if properly 
chosen, are able to prevent non-specific interactions between gold surface and 
analytes as well as to provide functional groups for protein conjugation [90-92]. 
Filamentous bacteriophages, such as fd and M13, have nanostructured 




Scheme 1i. Schematic representation of the bioinspired virus-gold microsphere. A 
thin gold layer allows facile surface modifications by thiol SAMs followed by 
chemical conjugation of functional proteins, such as streptavidin (streptavidin, 
                                           
i Dr. Inseong Hwang contributed to this scheme. 
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purple). The streptavidin-modified microspheres are decorated with pIII-biotinylated 
phage virions (pale blue) that have filamentous structure, resembling the surface 
morphology of some cells. The surface-exposed amine groups of N-terminal Ala-1 
(yellow stick) and Lys-8 (red stick) of the viral major coat proteins (blue for a single 
pVIII unit) are used for the Staudinger ligation with primary antibodies to yield 
microspheres covered with high-density antibodies. Protein figures were generated 
using VMD [94] based on PDB code 1IFJ. 
 
 
The viruses are comprised of five different kinds of structural proteins (pIII, 
pVI, pVII, pVIII, and pIX) that encase a single-stranded viral DNA. Among them, 
more than 2700 copies of the major coat protein pVIII serve for the assembly of 
filamentous structure with their ε-amino groups of Lys-8 and α-amino groups of N-
termini being exposed, each of which have been successfully modified with 
macromolecules using chemical conjugation [80, 95-97]. A minor coat protein pIII, 
three to five copies per virion, has been dominantly used for the display of peptides 
and proteins (Scheme 1) [55]. 
The filamentous morphology of the filamentous (fd) virus provides unique 
opportunity to construct bioinspired architectures because the virus has similar 
structural dimensions to many cellular threadlike structures that leverage various 
cellular functions. Furthermore, in biorecognition processes, such as ligand-receptor 
interactions, longer and flexible tethers and polyvalency have proved to be beneficial 
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[98-101]. Indeed, in biological systems, neuronal cells are rich in neurites and 
filopodia that maximize the cellular interactions by forming synapses [102]. 
Leukocytes, macrophages, and some epithelial cells are covered with microvilli that 
facilitate cellular movement, adhesion, endocytosis, and exocytosis [103]. Similarly, 
some bacterial cells represent pili that help cell–cell interactions essential for mating; 
others have fimbriae that aid adhesion [104, 105]. Based on these observations, we 
reasoned that the surface of gold microspheres, once modified with nanostructured 
filamentous virions, would have greater surface to volume ratio, mimicking 
biological architectures and thus allowing high degree of conjugation with functional 
molecules, such as antibodies. Such an increased ratio of antibody to biomarkers, 
together with three-dimensional gold-SAM protected surface of microspheres and 
microvilli-like long virus tethers, would provide improved performance compared 












3. Experimental methods 
 
3.1. Reagents 
Sulfo-N-hydroxysulfosuccinimide (Sulfo-NHS), sulfo-NHS-phosphine, NHS-
PEG12-azide, Streptavidin-coupled Dynabeads Myone T1 and 1-ethyl-3-[3-
dimethylaminopropyl] carbodiimide hydrochloride (EDC) were purchased from 
Thermo Scientific (Rockford, IL). Carboxyl-terminated hexa(ethylene glycol) 
undecane thiol (CMT002) was obtained from Nanoscience Instruments (Phoenix, 
AZ). Biotin-terminated daca(ethylene glycon) ethane thiol (41156-1095) was 
purchased from Polypure (Oslo, Norway). Carbenicillin (Carb) and isopropyl β -D-
1-thiogalactopyranoside (IPTG) were from Gold Biotechnology (St. Louis, MO). 
Streptavidin (SAV), bovine serum albumin (BSA), tetracycline (Tet), Tween-20, 
adenosine 5′-triphosphate (ATP), and cardiac troponin I (cTnI) were purchased from 
Sigma-Aldrich (St. Louis, MO). Plasmid pET21a-BirA was obtained from Addgene 
(Cambridge, MA). Magnetic gold microspheres (M-NG0501, Nomadien.com) were 
generated using proprietary methods including electroless plating of auric acids on 
proprietary magnetic poly(methyl methacrylate) (PMMA) beads (Nomadien.com) 
that were 15 μm in diameter. Nominal 10 μm diameter carboxylated polystyrene (PS) 
beads were from Polysciences (Warrington, PA). Phage vector, fd-tet with Sfi I and 
Not I cloning site in front of pIII, was kindly provided by Drs. Philipp Holliger and 
Chang-Hoon Nam. Rabbit polyclonal anti-fd (ab6188) and anti-cTnI (ab47003) 
 
24 
antibodies were purchased from Abcam (Cambridge, MA). Mouse monoclonal anti-
cTnI antibody [19C7] was from GeneTex (Irvine, CA). Chicken Alexa Fluor 594 
anti-mouse antibody (A21201), goat Alexa Fluor 610-R-Phycoerythrin (PE) anti-
rabbit antibody, Alexa Fluor 594 biocytin, streptavidin conjugated with horseradish 
peroxidase (streptavidin-HRP), biotin, and bacterial cell lines for protein expression 
and phage amplification were obtained from Invitrogen (Carlsbad, CA). Myoglobin, 
rabbit polyclonal anti-myoglobin antibody (70-MR13), and mouse monoclonal anti-
myoglobin antibody (10-M50A) were from Fitzgerald (North Acton, MA). 
 
3.2. Fluorescence microscopy 
Gold microspheres (~ 500) in phosphate buffered saline (PBS, 5 μL) were spotted 
on a glass slide. The fluorescence was monitored using Nikon Ti-E (Nikon, Japan) 
equipped with zyla sCMOS camera (Andor, Northern Ireland). At least thirty 
microspheres were chosen for the determination of mean fluorescence intensity (MFI) 
using NIS-Elements software version 4.2 (Nikon, Japan). 
 
3.3. Field-Emission Scanning Electron Microscopy (FE-SEM) 
The surface morphology of gold microspheres on a carbon tape was monitored using 
JSM 5410LV (JEOL, Japan) with 2 kV of acceleration voltage at the National 
Instrumentation Center for Environmental Management (NICEM), Seoul National 
University. To monitor the surface morphology of gold microspheres modified with 
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thiol SAM, streptavidin, and phage virions, Pt was sputtered using BAL-TEC SCD 
005 sputter coater at 15 mA for 100 s. 
 
3.4. N-SIM super resolution microscopy 
Fd-tet-APpIII phage virions on streptavidin coated microspheres were detected using 
rabbio anti-fd antibody and anti-rabbit alexa Fluor 488 antibody. Phage decorated 
microspheres in PBS (5 μm) were spotted on a glass slide. The fluorescence was 
monitored using N-SIM super resolution microscope (Nikon, Japan) at the 
Boimedical Imaging Center (BIM) of Seoul National University. 
 
3.5. Production of BirA 
His-tagged BirA was prepared according to the provider’s protocol with conditional 
modifications. Briefly, the pET21a- BirA plasmid was transformed into E. coli 
BL21(DE3)pLysS, plated on lysogeny broth (LB)-agar with Carb (100 μg/mL). A 
single colony was inoculated into LB-Carb media and was grown until the cell 
density reached mid-log phase when IPTG (1.0 mM) was added for induction. After 
overnight incubation at 37 °C, the cells were harvested, broken by sonication, and 
centrifuged. The supernatant was loaded onto Co-NTA column to purify His-tagged 
BirA. Typically, a small-scale pilot test was performed using seven individual 




3.6. Production of phages carrying biotinylation motif  
The two primers, AP-F (5′-CGG CCA TGG CAG GTC TGA ACG ACA TCT TCG 
AGG CTC AGA AAA TCG AAT GGC ACG AAG GCT CCG GTG C-3′) and AP-
R (5′- GGC CGC ACC GGA GCC TTC GTG CCA TTC GAT TTT CTG AGC CTC 
GAA GAT GTC GTT CAG ACC TGC CAT GGC CGG CT-3′), were annealed and 
ligated with fd-tet phage vector that had been digested with Sfi I and Not I. After the 
verification of the ligation by DNA sequencing, the phage vector was transformed 
into E. coli TG1 and grown in LB agar plate containing Tet (40 μg/mL) for 16 h at 
37 °C, the Next morning, a single colony was picked and inoculated into 3 mL of 
NZY liquid media with Tet (20 μg/mL) as a starter culture. For large-scale phage 
preparation, the starter culture was inoculated into NZY-Tet media (400 mL) and 
grown for 16 h at 37 °C with vigorous shaking. Phages were then purified by 
polyethylene glycol (PEG)/NaCl precipitation according to the standard protocols. 
 
3.7. Biotinylation of phages 
The purified phage virions (1013) were incubated with BirA (30 nM), biotin (100 
μM), and ATP (1 mM) in PBS-Mg (0.5 mL, pH 7.4 with 5 mM MgCl2 ) for 2 h at 
37 °C. The phages were then precipitated by PEG/NaCl two times and the residual 
PEG/NaCl molecules were removed by buffer exchange using Centricon (MWCO = 




3.8. Surface modifications of gold microspheres 
Gold microspheres (1 mg) was rotary incubated with thiol SAM molecules (1 mM) 
in 0.5 mL of ethanol for 16 h at 25°C. To the SAM-modified gold microspheres (5 
μg) was added EDC (2 mM) and NHS (5 mM) in 0.5 mL of MES buffer, pH 5.0 for 
30 min at 25 °C. The beads were then washed with PBS (1 mL, pH 7.4) three times, 
followed by the addition of streptavidin (0.5 mg) in PBS (50 μL). The streptavidin-
modified microspheres were treated with PBS-BT (PBS with 1% BSA, 0.1% Tween-
20, pH 7.4) for 30 min and the streptavidin loading was verified using biocytin-Alexa 
Fluor 594. 
 
3.9. Optimization of phage loading onto gold microspheres 
A range of biotinylated phage virions were rotary incubated with streptavidin-
modified gold microspheres (5 μg) in PBS-BT (50 μL) for 16 h at 25 °C. As a 
negative control, wild-type fd-tet virions were used. After washing three times with 
PBS, the beads were treated with anti-fd rabbit IgG (37 ng) in PBS (50 μL) for 1 h 
at 25 °C. After washing, the loading of phage virions were visualized by incubating 
with anti-rabbit Alexa Fluor 610-R-PE antibody (100 ng) in PBS (50 μL) for 1 h at 
25 °C, followed by the monitoring with a fluorescence microscope. 
 
3.10. Optimization of staudinger ligation 
Streptavidin-modified beads (5 μg) were incubated with varying amount of sulfo-
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NHS-phosphine in PBS (0.5 mL) for 1 h at 25 °C, which were used as a positive 
control. To build virus-immobilized beads, the streptavidin-modified beads were 
further incubated with 1.0 × 1010 of biotinylated phages in PBS-BT (50 μL) for 16 h 
at 25 °C, washed three times with PBS-BT and three times with PBS, followed by 
an incubation with a range of Sulfo-NHS-Phosphine in PBS (0.5 mL) for 1 h at 25 °C. 
For the Staudinger ligation, primary antibody from mouse (100 μg) was incubated 
with NHS-PEG12-azide (0.1 and 1.0 mM) in of PBS (0.1 mL) for 1 h at 25 °C, 
followed by overnight dialysis against PBS. The phosphine-treated streptavidin- and 
virus-gold microspheres (5 μg) were ligated with the azide-modified mouse antibody 
(0.5 μg) in PBS for 4 h at 37 °C. The resulting beads were then washed three times 
with PBS-BT, followed by the incubation with anti-mouse Alexa Fluor 594 antibody 
for the fluorescence microscopic analysis. As a negative control, anti-mouse Alexa 
Fluor 594 antibody was directly treated with streptavidin- and virus-beads without 
azide-modified antibody and the background signals, if any, were subtracted. 
 
3.11. Cardiac marker assays 
Initially, the streptavidin- and virus-gold microspheres (5 μg) were treated with 
sulfo-NHS-phosphine (0.5 mM) in PBS (0.5 mL) for 1 h at 25 °C, followed by the 
ligation with rabbit polyclonal anti-cTnI capture antibodies (0.5 μg) that had been 
incubated with NHS-PEG12-azide (100 μM) in PBS (50 μL) for 4 h at 37 °C. The 
resulting beads were then washed three times with PBS-BT and were mixed with 
cTnI (0.02, 0.2, 2, and 10 ng/mL) or myoglobin (0.02, 0.2, 2, 10, 40, and 100 ng/mL) 
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in PBS (0.5 mL) for 1 h at 25 °C. For the detection of cTnI in human serum, PBS 
was replaced with cTnI-spiked human serum (0.02, 0.2, 2, and 10 ng/mL in 0.5 mL). 
The beads were then washed, incubated with mouse monoclonal anti-cTnI detection 
antibody [19C7] in PBS (500 ng, 50 μL) for 1 hr at 25 °C, and visualized with anti-
mouse Alexa Fluor 594 antibody (500 ng). For the determination of background 












4. Results and Discussion 
 
4.1. Characterization of magnetic gold microshells 
Beads that are used in suspension arrays for bio-analysis are of low density and most 
of them use polymer microspheres, which are amenable to surface modification. 
However, these beads are not free from non-specific adsorption, which is a problem 
not only because it leads to adsorption of non-specific species into the microsphere 
surface, but also because of the introduction of these species into the polymer 
microsphere core. Therefore, in this study, we used gold microshells from Nomadien 
Corp. (www.nomadien.com), which consist of a thin gold layer that forms a metal 
barrier that blocks contact between the polymer core and external solution 
fundamentally while easily facilitating surface modification. Iron oxide was 
introduced into the poly(methyl methacrylate) (PMMA) surface to make the beads 
magnetic, and finally a gold layer was added using electroless plating (Figure 3a). 
The gold layer was approximately 200 nm thick, as verified by TEM (Figure. 3c), 







Figure 3. (a) SEM image of iron oxide embedded 15 μm magnetic gold microshells. 
TEM images of magnetic gold microshells (b) and (c). As shown in (c), the thin gold 







4.1.1. Testing the physical and chemical stability of gold microshells 
To measure the physical and chemical stability of the gold microshells, a 5 μg gold 
microshell was added to ethanol, dimethyl sulfoxide, N,N-dimethylformamide or 
1,4-dioxane solution. This was followed by sonication for 30 minutes and incubation 





Figure 4. Solvent test of gold microspheres. SEM images of gold microshells that 
were put into (a) PBS buffer, (b) ethanol, (c) dimethyl sulfoxide, (d) N,N-
dimethylformamide, or (e) 1,4-dioxane, followed by 30 minutes of sonication and a 





As shown in Figure 4, separation of the gold layer was observed as a swelling 
of the polymer microsphere in the organic solution. Separation of the gold layer was 
also observed when sonication was performed for more than 30 min. We did not 
observe cracking of the gold layer in the water and ethanol solution (Figure 4a-b). 
Thus, we confirmed that the gold layer is stable in an ethanol solution and remain 
stables even after up to three minutes of sonication. 
Next, we prepared SAM-protected gold microspheres using carboxyl-
terminated hexa(ethylene glycol) undecane thiol, followed by protein conjugation 
using 1-ethyl-3-(3-dimethylaminopropyl)-1-carbodiimide hydrochloride (EDC) and 
N-hydroxysuccinimide (NHS). The gold-layered microspheres were stable in 
ethanol for 16 h, enough time for SAM formation. The bead system facilitated 
chemical conjugation of protein on the SAM-modified gold microspheres using 
EDC-NHS in that the unreacted excessive EDC and NHS could be easily washed 
out. When gold microshell powder was added to the solution, the gold-gold affinity 
increased, resulting in aggregation (Figure 5a). However, because the SAM-
protected gold microshells have a high affinity for gold-thiol, they formed single 
beads (Figure 5b). The SAM-protected gold microshells were well dispersed in the 







Figure 5. (a) Optical image of the gold microshell before the SAMs were formed (b) 
Optical image of the gold microshell after the SAMs were formed (c) Dispersion 
state in the solution after the SAMs were formed (d) Image at 30 seconds after a 
magnet was placed beside the tube.  
 
 
To investigate the effect of temperature on SAM formation, SAM-modified 
gold microshells were incubated for 24 hours at either 4 °C or 25 °C and then 
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incubated with Alexa 594 conjugated biocytin at 4 °C, 25 °C or 40 °C. As shown in 
Figure 6, the fluorescence values for all samples were not significantly different 
within the error range. This result indicates that there was no desorption of SAM 
molecules at either 4 °C or 25 °C and there was no effect of temperature on 




Figure 6.  Verification of the stability of SAM-modified gold microshells. SAM-
protected gold microshells were incubated in phosphate-buffered saline (PBS) buffer 
at (a) 4 °C or (b) 25 °C for 24 hours. Each of (a) and (b) samples was incubated at 
4 °C , 25 °C , 40 °C for 24 hours and then treated with streptavidin and biocytin-
alexa594 for 1 hour at 25 °C to observe fluorescence. Biocytin-Alexa Fluor 594 dye 





4.1.2. Protein immobilization of gold microshells 
Having verified the stability of the thiol SAMs-treated gold microshells, we wanted 
to determine whether the protein could be incorporated into them. After activating 
the carboxyl-terminated gold microshells using EDC/NHS, the primary antibody 
was covalently attached and fluorescence was observed using an alexa488 
conjugated secondary antibody (Figure 8a). As shown in Figure 7c, green 





Figure 7. (a) Schematic representation of antibody immobilization on carboxyl-
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terminated gold microshells. After the primary antibody was attached to the surface 
of the gold microshells using EDC/NHS, the reaction was observed via fluorescence 
with an alexa488 conjugated secondary antibody. (b) DIC image. (c) Fluorescence 
image. 
To optimize protein immobilization on the gold microshells, we tested different 
numbers of gold microshells, antibody concentrations, working volumes, and 
reaction times. Full-length IgG antibodies have a molecular weight of 150 kDa and 
a size of 3 nm × 15 nm × 15 nm, and we assumed their area as 2 nm × 4 nm. Given 
the three-dimensional curvature of the microspheres, the degree of freedom of 
polyethylene glycol and the size of a single chain fixed at the surface, we estimated 
that 5 μg of 15 μm sized gold microshells would require 24 ng of antibody. The 
following conditions were fixed: 5 μg gold microshells, 500 μL working volume, 1 
h reaction time, and 2 μg secondary antibody. Only the amount of primary antibody 
was changed, and the degree of protein attachment was determined by the level of 
fluorescence (Figure 8a). A fluorescence value for the ratio of experimental value to 
theoretical value of the antibody was determined (Figure 8c), and with the use of 
approximately more than 20 times the amount of antibody, saturated fluorescence 
was found such that 500 ng used with 5 μg of gold microshells was sufficient. Thus, 
results from this experiment indicate that when proteins were fixed and secondary 






Figure 8. Optimization of antibody loading on gold microshells. (a) Schematic 
representation of antibody immobilization on thiol SAM-decorated gold microshells. 
(b) DIC and fluorescence images with different amounts of primary antibody, and a 
fixed amount of secondary antibody. (c) Fluorescence intensity according to the ratio 





Scheme 2. Schematic representation of streptavidin immobilization on gold 
microshells to determine the quenching effect. (b) and (d) are a control experiment 
after pretreatment with free biotin. (a) and (b) are pretreatments without albumin.  
 
 
Next, we evaluated streptavidin conjugation using biocytin-Alexa Fluor 594 
and biocytin-Alexa Fluor 488 (Scheme 2). When the beads were pre-treated with 
free biotin, no fluorescence was observed after incubation with fluorescent biocytin 
(Figure 9b and d). In contrast, we observed strong fluorescence signals when the 
beads were directly incubated with the fluorescent biocytin (Figure 9 Lower panel a, 
c). Unexpectedly, no green fluorescence was observed following incubation with 
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biocytin-Alexa Fluor488 (Figure 9 Upper panels a, c). This could be because the 
green fluorescence was quenched by the gold because there is some overlap between 
the maximum absorption wavelength of the absorption spectrum in the gold visible 
light region and the green region. Thus, we repeated the experiments only using red 
based fluorescence (biocytin-Alexa 594) and were able to observe fluorescence on 
the beads (Figure 9). In addition, in bio-analysis experiments, and in particular those 
involving blood, it is possible that proteins in the serum, such as albumin, could be 
a problem when using the polymer microspheres. However, we showed that there 
was no significant difference in fluorescence values following pretreatment with 






Figure 9. Results of streptavidin immobilization on gold microshells. In (a) and (c), 
experiments using biocytin-Alexa 488 (upper panels) did not show fluorescence due 
to quenching whereas biocytin-Alexa 594 (lower panels) showed strong 






4.1.3. Sandwich immunoassay of antibody-decorated gold microshells 
Using antibody-decorated gold microshells fixed directly with SAM molecules, a 
spike test of cardiac troponin I was conducted in human serum. A polyclonal 
antibody was covalently attached to the gold microshell using EDC/NHS and a 
sandwich-type immunoassay was performed after detecting a biomarker from the 
human serum (Scheme 3). For the control experiments, a carboxyl-terminated 
polymer microsphere was used and conditions without a biomarker or without a 
monoclonal antibody were compared to determine the level of fluorescence caused 









Figure 10. Detection of cardiac troponin I in human serum. 
 
 
We verified that the mean fluorescence intensity (MFI) was approximately 150 
for the gold microshells when 100 nm/mL cardiac troponin I was spiked in human 
serum. For polymer microspheres, high background fluorescence of 70 MFI was 
measured. This value was similar to that of a control sample in the absence of cardiac 
troponin I due to non-specific adsorption of secondary antibody. Gold microshells 
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in the absence of cardiac troponin I had a MFI value of approximately 5, which 
indicated significantly low non-specific adsorption. We inferred that this was due to 
the effect of the polyethylene glycol in the thiol SAM molecule and a thin gold layer 
that forms a metal barrier and blocks contact with the polymer core. Our colleague, 
S. R. Kwon, discovered how to prevent non-specific adsorption effectively using the 
same magnetic gold microshell and PEG-thiol SAM molecules that we used through 
MALDI analysis [106]. S. R. Kwon et al. shows the MALDI-TOF mass spectra for 
commercial polymer microspheres and for the magnetic gold microshells used in our 
experiments. A human serum albumin peak of non-specific adsorption was detected 
at 33 and 66 kDa , but was not detected with magnetic gold microshells. The 
detection ability of Myoglobin, which is a target biomarker, showed that the 
magnetic gold microshells had the best result. Based on the above results, 
polyethylene glycol and the metal barrier are both effective at suppressing non-
specific adsorption. 
 
4.2. Preparation and characterization of engineered phage virions 
To prepare microshells covered with threadlike nanostructured surface, we 
employed fd-tet phage virus that has intriguing morphology similar to cellular 
microvilli-like edifice. A 14-mer bacterial biotin acceptor peptide (AP), 
GLNDIFEAQKIEWHE [107], was introduced using SfiI and NotI cloning sites in 






Figure 11. (a) Phage vector map, fd-tet with SfiI and NotI cloning site in front of pIII. 
(b) Wild-type fd-tet and AP-representing fd-tet-APpIII virions (1013) were treated 
with BirA, followed by western blot visualized using streptavidin-HRP. (c) The two 
primer, SfiI-Avitag-NotI-F and SfiI-Avitag-NotI-R, were annealed and ligated with 
fd-tet phage vector (a) that had been digested with SfiI and NotI. 
 
 
Since the ε-amino group of Lys, a specific biotinylation site within the AP tag, 
is vulnerable to chemical modification by NHS for the subsequent Staudinger 
ligation, we tried in vivo biotinylation of phages by endogenous biotin ligase BirA 
that recognize AP in bacterial cells [107]. The degree of in vivo biotinylation, 
however, was minute, making us to purify BirA and biotinylate the virions in vitro 
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[109]. When we incubated AP-containing phage (fd-tet-APpIII) with BirA, distinct 
bands (~60 kDa) appeared in a western blot using streptavidin-HRP (Figure 11b) and 






Figure 12. TEM image of PEG/NaCl-purified fd-tet-APpIII phage after 2% uranyl 





4.3 Evaluation and optimization of virus-decorated gold 
microshells 
We then briefly evaluated the loading of virions on streptavidin-gold microspheres 
and found saturated fluorescence signals using 1.0 × 1010 virions and 5 μg of 
streptavidin-gold microspheres (Figure 13). Given that the apparent diameter of 
terminal N1-N2 domain of pIII is ~6 nm and the tail part of the fd virus is composed 
of three to five copies of pIII [110], one virion may be ensconced in an area of ~8.5 
× 10-17 - 1.4 × 10-16 m2. Since 5 μg of gold microspheres corresponds to ~1,000 beads, 
the total surface area of the beads is ~7 × 10-7 m2 on which ~5-8 × 109 of virions can 
be accommodated without gaps in theory. 
 
Figure 13. BirA-treated fd-tet (upper panel) and fd-tet-APpIII (lower panel) phage 
virions (1.0 × 1010) on streptavidin-SAM gold microspheres were detected using 
(a) Alexa Fluor®  610 Succinimidyl Esters, (b) rabbit anti-fd antibody and anti-





Figure 14. Optimization of surface modifications of gold microspheres with 
streptavidin and phage virions. Various amount of biotinylated phage virions were 




Indeed, when we titrated the loading of virions on the microspheres, the 
fluorescence intensity began to plateau from 1.0 × 1010 virions near the theoretical 
value (Figure 14). Thus, we used 1.0 × 1010 virions to maximize antibody loading 


































4.4 Visualization of virus-decorated gold microshells 
We next compared the surfaces of gold microspheres before and after the phage 
immobilization. Figure 15a and b are the FE-SEM images of bare gold microspheres 
that reveal gold granules layered on the surface of microspheres. After thiol SAM 
formation, gold surface maintained the overall roughness similar to the bare gold 
surface (Figure 15c). By contrast, streptavidin-modified surface exhibited tiny 
pimples, believed to be Pt-coated streptavidin, added on the gold granular blocks 
(Figure 15d and Figure 16a). Furthermore, in the case of virus-modified surface, we 
could clearly identify the virion fibers on the streptavidin layer with the increased 
thicknesses of 10~15 nm due to the sputtered Pt (Figure 15e and Figure 16b). The 
virion strands appeared to lie down because of the dry conditions and Pt sputtering 






Figure 15. (a) SEM image of bare magnetic gold microspheres (scale bar = 10 μm). 
(b) Magnified image of gold microspheres reveals the morphology of gold layer 
(scale bar = 2 μm). Pt-sputtered surface morphology of the beads that had been 
modified with carboxyl-terminated hexa(ethylene glycol) undecane thiol SAM (c), 
then conjugated with streptavidin (d), and finally with pIII-biotinylated fd-tet phage 







Figure 16. (a) SEM images of independent areas of streptavidin-modified gold 
microshells with Pt sputtering. (b) SEM images of independent areas of streptavidin-




The presence of virus on the streptavidin-decorated gold microshells was 
verified via FE-SEM imaging, however the actual location of the virus in the solution 
was not known. To determine this, we used Alexa Fluor®  488 Succinimidyl ester, 
which is an amine-reactive dye and introduced fluorescence to the primary amine of 
the protein fixed at the bead in order to visualize the location of the virus in the 
solution. In contrast to streptavidin-coated beads in the absence of virus, the virus-
decorated beads were well established within the three-dimensional space (Figure 
17). As such, fixation using a virus rather than fixing an antibody directly onto the 
bead will increase the availability of the antibody and ultimately increase the 
frequency of ligand-receptor interactions. 
 
 
Figure 17. 3D N-SIM super resolution image from a 100 nm Z-stack step size and 
0.1 reconstruction factor. w/o phage (a) and w/ phage (b) (scale bar = 1 μm) at 1 
μm streptavidin-coated microsphere. 
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4.5 Optimization of the Staudinger ligation 
Staudinger ligation, an extended version of classical Staudinger reaction, has been 
rediscovered by Saxon and Bertozzi [111]. Among several bioconjugation 
techniques, the Staudinger ligation has garnered much interest in that it has highly 
chemoselective and bio-orthogonal conjugation mechanism (Scheme 4). 
Consequently, the Staudinger ligation has been deployed not only to label glycans, 
lipids, nucleic acids, proteins, and cell surface, but also to manufacture glycopeptides, 
microarrays, and biopolymers. To keep the intact filamentous structure of the virions 
on microspheres, conjugation reactions should be devoid of intra- and inter-
molecular crosslinking of the virions, while not interfering with a directional binding 
of virion tips to microspheres. To that end, we selectively biotinylated pIII parts for 
the orientation-controlled immobilization of fd virions and thereby used the 
Staudinger ligation, a bioorthogonal and chemoselective crosslinking between azide 






Scheme 4ii. Schematic representation of the fabrication of bio-inspired virus-gold 
microsphere. (a) The Staudinger ligation (azide-phosphine conjugation) between 
phosphine-activated A and azide-labeled B. An aza-ylide intermediate (middle) 
converts to a stable covalent amide bond (right). (b) A thin layer of gold allow facile 
surface modifications by thiol SAM followed by chemical conjugation of 
streptavidin. The resulting streptavidin-modified microspheres are decorated with 
pIII-biotinylated phage virions that have filamentous structure, resembling the 
surface morphology of specific types of cells. The surface-exposed anime groups of 
N-termini of the viral major coat proteins are conjugated with phosphine and mixed 
with azide-modified primary antibodies to yield microspheres covered with high-
density antibodies via bioorthogonal Staudinger ligation (figures shown cross-
sectional area of virions layer and not drawn to scale). 
                                           
ii Dr. Inseong Hwang contributed to this scheme. 
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We then optimized antibody labeling with either amine-reactive NHS-PEG12-
Azide or Sulfo-NHS-Phosphine. In our experimental conditions, antibody 
precipitated after incubation with Sulfo-NHS-Phosphine probably because of the 
increased hydrophobicity stems from the phenyl groups of phosphine. On the 
contrary, no antibody precipitate was found with NHS-PEG12-Azide, and no visible 
changes of streptavidin- and virus-beads were observed after labeling with Sulfo-
NHS-Phosphine; streptavidin is already fixed on the beads, allowing no further 
aggregation, and phages are rich in surface charges that negate the effect of increased 
hydrophobicity. After ligation of the azide-modified primary antibody and the 
phosphine-modified beads, we stained the beads with fluorochrome-labeled 




Figure 18. Optimization of Staudinger ligation using mouse antibody. (a) Gold 
microspheres, covered with streptavidin or phage virions, were treated with four 
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different concentrations of Sulfo-NHS-Phosphine, while mouse antibody were 
incubated with 0.1 mM and 1.0 mM NHS-PEG12-Azide. (b) streptavidin or phage-
covered gold microspheres were incubated with fixed concentration of phosphine 
(0.5 mM), while the concentration of azide varied. Anti-mouse Alexa Fluor 594 
antibody was used for the determination of mean fluorescence intensity (MFI). 
 
 
We found that the optimum concentration of phosphine was around 0.5 mM 
with 100 μM azide where, among others, the virus-tethered beads exhibited the 
highest fluorescence intensity (Figure 18a). The efficiency of antibody loading 
decreased at higher concentration of azide (1.0 mM) probably because of the limited 
access of secondary antibody to buried epitopes of the primary antibody. Lower 
amount of azide (20 μM) did not seem to push efficacious Staudinger ligation (Figure 
18b). However, we cannot rule out the possibility that the lower the level of azide 
modification, the better the antibody activity. 
 
4.6 Sandwich immunoassay of cardiac biomarkers 
To demonstrate the effect of long virus threads, after antibody loading we compared 
the biomimetic virus-beads with streptavidin-coated beads in terms of antibody 






Figure 19. Sandwich immunoassay profiles (top) and representative fluorescence 
images of each functionalized microspheres corresponding to the w/o initial and final 
concentrations (bottom) tested for cardiac marker proteins. A range of cTnI in PBS 
(a), myoglobin in PBS (b), and cTnI in serum (c) were detected using virus- and 






We focused on the low range of cTnI and relatively higher range of myoglobin 
concentrations on the basis of clinical applications [112]. In immunoassays using 
cTnI- and myoglobin-spiked PBS, virus-decorated gold microspheres showed 
markedly enhanced signals compared to streptavidin-modified gold microspheres 
(Figure 19a and b). We could detect as low as 0.2 ng/mL of cTnI and myoglobin 
using virus-beads. The signals from streptavidin-beads lingered with the background 
until the concentration reached 2.0 ng/mL of cTnI and myoglobin. The effect of 
virions was more dramatic in the higher range of cTnI concentration with up to 9-
fold increase in fluorescence signal at 10 ng/mL, while the effect of virions on 
myoglobin showed 2-fold increase within the concentration range tested. The 
difference in fold increase may originate from the intrinsic variances of antigens, 
such as size, structure, and binding constant to primary antibodies. Note that the 
difference in assay performance is greater than the one in the antibody loading 
between the streptavidin- and virus-beads (see Figure 19). Furthermore, the effect of 
viral fibers stands out when the amount of captured antigens, and thus the detection 
antibodies in sandwich assay, is limiting. Therefore, the enhanced sensitivity of the 
virus-beads may be ascribed to the greater amount of antibody and the long and 
flexible virus filaments that increase receptor-ligand interactions. 
The preventive role of SAM-gold layer for nonspecific adsorption was marked 
in immunoassays using serum samples that were spiked with cTnI. Interestingly, 
both the virus- and streptavidin-beads detected as low as 20 pg/mL of cTnI (Figure 
19c), while the streptavidin-beads exhibited partial improvement at higher 
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concentration of cTnI (10 ng/mL) with two fold lower sensitivity than the virus-
beads. Importantly, we observed concentration-dependent increase of fluorescence 
signals at lower range of cTnI only in the case of virus-beads. By contrast, typical 
carboxylated polystyrene (PS) beads, on which antibodies were conjugated with 
EDC-NHS chemistry, failed to produce any signals throughout the range tested in 
serum, although the beads were able to detect cTnI in PBS (Figure 20). 
 
 
Figure 20. Immunoassay of cTnI in PBS buffer (10 ng/mL) using 10 μm-diameter 
polystyrene beads whose surfaces were modified with an anti-cTnI antibody using 
EDC/NHS chemistry. (a) DIC image. (b) Fluorescence image.  
 
 
The reason why the sensitivity for cTnI in serum should increase remains 
obscure, although the results suggest that the dense antibodies on phage tentacles 
and the SAM-gold protection layer synergistically enhance the sensitivity for the 
lower range of marker proteins. 
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5. Conclusion and Perspective 
 
In cellular systems, threadlike protruding structures have been evolved to sustain 
efficacious cellular functions, such as cellular uptake of small- and large molecules, 
cellular adhesions to biological and non-biological matrices, cell-cell interactions, 
and ligand-receptor interactions. Inspired by the cellular morphology and by the 
additive effect of long tethers on receptor-ligand interactions, we decorated SAM-
protected gold microspheres with filamentous virions that mimic microvilli-like 
biological architectures. The SAM-protected virus-gold microspheres showed 
extremely low non-specific bindings, enhanced capacity of antibody loading, and 
superior performance in analyte-solid surface interactions when compared with bare 
polymer beads and non-viral streptavidin-gold beads. The gold-protected and virus-
tethered microbeads that resemble biological architectures will open up new 
possibilities for developing biocompatible and bio-inspired solid surfaces for the 
improved analyte-solid surface interactions. The microsphere, which is the key to 
the multiplex suspension array, can be replaced with the virus-decorated gold 
microshells we developed. This is applicable to the entire field of in-vitro diagnoses 
and feasible for point-of-care testing (POCT) in combination with microfluidics. 
Also, since gold microshells with a thin gold layer themselves conduct electricity, 
they could be used in electrical connections in printed circuit boards or connections 









Cell-solid surface interaction: 
Purified synaptic cell adhesion molecules for 



















A neuron is the main cell constituting the nervous system. Unlike other cells, it can 
transfer electrical signals, and can be classified into various types according to 
location and function. A typical neuron is composed of the cell body, called a soma, 
the signal receptors, called dendrites, and the main channel of signal transmission, 
called an axon. In the nervous system, neuron-to-neuron communication occurs by 
electrical or chemical signals passing through the neuron junctions (synapses). A 
typical synapse consists of a connection between the axon of one neuron and a 
dendrite or soma of another. The electrical signals are transmitted by the presynaptic 
axons and are transformed into chemical signals (neurotransmitters) in synapses 
where the probability of the transmission of the electrical signals to postsynaptic 
dendrites is determined by the types of the neurotransmitters. Excitatory synapses 
allow postsynaptic transmission of electrical signals, inhibitory synapses block 
postsynaptic transmission of the signals. 
In-depth analysis of the signal transmissions between the axon and synapse 
reveals that they are ultimately a local movement of chemical species, and such 
changes in their electrochemical potential allow external stimulation or 
measurements of signals within the cell. Currently, in most studies, excluding the 
patch clamp method, neuronal cells are simply developed on or near a solid electrode 
surface to receive cellular signals. 
E.G. Gray elucidated the structure of a synapse using an electron microscope in 
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1959 [113]. Synapses are ~1 μm in diameter with an intercellular space called 
synaptic cleft, which is ~20 nm wide, and their formation requires mutual pairing 
between cell adhesion molecules (CAMs). Synaptic CAMs are proteins localized on 
the cell surface that adhere to the pre- and post- synaptic terminals and increase the 
mechanical stabilization of the synapse, while modulating its structure and function. 
Generally, synaptic CAMs consist of 3 domains: the intracellular domain that 
interacts with intracellular scaffold proteins, the transmembrane domain, and an 
extracellular domain that interacts with other Synaptic CAMs. Several families of 
Synaptic CAMs have been discovered [114], including neuroligins (NLs), neurexins 
(Nrxs), Slit and Trk-like family (Slitrks), netrin-G ligand proteins (NGLs), leucine-
rich repeat transmembrane neuronal proteins (LRRTMs), neural cell adhesion 
molecules (NCAM), L1-cell adhesion molecules (L1-CAMs), synaptic adhesion-
like molecules (SALMs), etc (Table 4). 
Most attempts in the formation of artificial synapses started from the year 2000 
when seminal experiments were reported on stable synaptic junctions between non-
neuronal cells expressing synaptic CAMs and cultured neuronal cells [115, 116, 121]. 
Recently, the purified synaptic CAMs were immobilized on a solid surface to induce 









NLs post Nrxs, PSD-95 Excitatory synapse formation (NL1) 
Slitrks post PTPδ Inhibitory synapse formation 
(Slitrk3) 
NGLs post PTPσ, etc Maintain excitatory synaptic current 
(NGL3) 
LRRTMs post Nrxs Excitatory synapse formation 
Nrxs pre NLs, LRRTMs Induce post-synaptic differentiation 
(β-Nrx) 
L1-CAMs pre - Decrease of inhibitory synaptic 
response (L1) 
SALMs both NMDAR, etc Control of excitatory synapse 
maturation (SALM2) 
pre, pre-synaptic; post, post-synaptic; both, pre- and post-synaptic; PSD-95, post-





Among other synaptic CAMs, NLs and Nrxs are the most studied proteins; rats 
and mice have three genes encoding NLs, whereas humans have five. Previously in 
1995, Südhof et al. first purified NL1 using affinity chromatography with 
immobilized Nrx-1β [119], and the complete paired structure of NL1 and Nrx-1β 
was revealed in 2007 [120]. Scheiffele et al expressed NLs in HEK-293 cells, co-
cultured them with neuronal cells [121], and discovered that NL1 triggers pre-
synaptic development. Similarly, Südhof et al. transfected NL1 derivatives into COS 
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cells and showed that this induced the formation of an artificial synapse [122]. 
Furthermore, Groves and coworkers immobilized a glycosylphosphatidylinositol 
(GPI)-linked NL1 ectodomain on silica microbeads covered with supported lipid 
bilayer (SLB) membrane, and confirmed the synaptogenic activity of the GPI-
anchored NL1 ectodomain [118]. On the other hand, Colman group used poly-D-
lysine (PDK)–coated polymer beads to induce the formation of artificial synapses 
without using synaptic CAMs [123]. Recently, research is being actively conducted 
on various synaptic CAMs and induced artificial synapses, but the function and 








Unlike the detection of delocalized analytes in solutions, the detection of 
extremely local neuronal signals (e.g., electrical signal or neurotransmitter) needs 
sophisticated regulation of distances between an electrode surface and cells. Studies 
have so far only stochastically localized the cells on a solid surface, which causes a 
loss in sensitivity, selectivity, and reproducibility. If we allow the cells to meet 
electrodes through the synaptic connections, we not only ensure the reproducible 
physical geometry of the cell-electrode interfaces, but also have the possibility to 
measure neurotransmitters otherwise impossible (Scheme 5). Therefore, it is 
expected that the synaptic CAMs, which were developed to induce artificial synapses 
on a solid surface, will allow us to consistently position the neuronal cells evenly, 
thereby providing reproducible and selective signal exchanges. Furthermore, the 
induced artificial synapses using synaptic CAMs will ultimately provide the 
foundation for the systematic study of interactions between the solid surface and the 
cells, as well as the understanding of the information processes in neural networks. 
   To understand and mimic neuronal network behavior, the ability to monitor, and 
thus distinguish between, the excitatory and inhibitory signals is essential. In 
biological systems, excitatory and inhibitory synapses are determined by synaptic 
CAMs [124, 125]. Notably, chemical conjugation of NL1 on polystyrene beads, 
despite their capability of adhering to Nrx-expressing cells, failed to induce 
presynaptic differentiation, suggesting that NL1 requires fluidic lipid bilayer 
environment for its activity [117]. As a consequence, the use of synaptic CAMs such 
as NL1 to build artificial synapses has been blocked by the lipid membranes that 
 
68 
create a huge insulating barrier between neurons and the signal recording materials, 
e.g., electrodes. When it comes to direct recording of neuronal signals via artificial 
synapses induced by synaptic CAMs, an electrode is expected to act as a ‘fake’ 
postsynaptic bouton, and thus the requirement of lipid bilayer on the electrode is a 
significant challenge. NL isoforms (NL1, 3, and 4) are well-known to induce the 
formation of excitatory (glutamatergic) presynapses, while NL2 and recently found 
Slitrk3 inhibitory (GABAergic) presynpases [126-129]. As synaptic CAMs for 
inhibitory synapses are quite rare, unprecedented specificity to inhibitory synapses 
of Slitrk3 is of importance [130, 131]. 
Here, we demonstrate functional interactions of fluorescent and biotinylated 
synaptic CAMs with cultured hippocampal neurons, independent of SLB media. The 
fluorescence tag should aid in establishing stable cell lines, and thus mass production, 












2. Experimental Methods 
 
2.1. Materials 
Plasmids encoding cholinesterase-like domain (CLD) of neuroligin-1 (NL1) 
followed by GPI anchoring motif (pNICE-HA-H6-NL1-GPI) and full length NL1 
and NL2 (pNICE-HA-H6-NL1 and pNICE-HA-NL2) were a generous gift from 
Peter Scheiffele. A plasmid carrying EYFP-tagged full length NL1 (pNICE-YFP-
NL1) was a kind gift from Ann Marie Craig. A plasmid encoding full length Slitrk3, 
pGW1-Slitrk3, was a kind gift from Jaewon Ko. A plasmid expressing TagRFP-T 
(pcDNA3-TagRFP-T) was kindly provided by Roger Y. Tsien. BirA expressing 
plasmids pDisplay-BirA-ER (Addgene plasmid #20856) and pET21a-BirA 
(Addgene plasmid #20857) were provided by Alice Ting. pAd:CMV-rtTA-IRES-
BirA was a gift from William Pu (Addgene plasmid #31375).  
Carbenicillin (Carb) was from Gold Biotechnology (St. Louis, MO). 
Streptavidin, bovine serum albumin (BSA) (A3059), adenosine 5’-triphosphate 
(ATP), polyethyleneimine (Mw: 25,000), Kanamycin sulfate, and G418 (Geneticin) 
were from Sigma-Aldrich (St. Louis, MO). QIAprep Spin Miniprep, QIAGEN 
Plasmid Plus Midi, QIAquick Gel Extraction, Phusion DNA polymerase, and Ni–
NTA resin were obtained from Qiagen (Seoul, Korea). Restriction enzymes and T4 
ligase were obtained from New England Biolabs (Ipswich, MA). Alexa-labeled 
secondary antibodies, bacterial cell line DH10B, mammalian cell line HEK293-H, 
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HEK-293, streptavidin conjugated with horseradish peroxidase (streptavidin-HRP), 
Opti-MEM®  I Reduced Serum Medium, Biocytin-Alexa 594, D-biotin, and 
Dynabeads®  M-280 Streptavidin were obtained from Life Technologies (Invitrogen, 
Carlsbad, CA). Goat NL1 polyclonal antibody (sc-14084) was from Santa Cruz 
Biotechnology, Inc. (Santa Cruz, CA) 
 
2.2. Molecular biology 
2.2.1. Y-NL1-G 
pNICE-YFP-NL1 was cut by KpnI and NotI to remove the predicted O-glycosylation 
motif (OG), transmembrane domain (TMD), and cytosolic domain of NL1 was 
replaced by GPI linker from pNICE-HA-H6-NL1-GPI by cutting with the same 
enzymes, yielding pNICE-YFP-NL1-GPI. 
 
2.2.2. Y-NL1 
The GPI portion of the pNICE-YFP-NL1-GPI was replaced with GS-linker 
(PHLHNLDI639 GGGSGGGSEGGGSGGGSGGGSEGGGSGG) fused with a 14-
mer biotin acceptor peptide (AP or AviTag, GLNDIFEAQKIEWHE). First, pNICE-
YFP-NL1-GPI and the staggered PCR product (primers N38, N39, N40 and N41) 
were digested with KpnI and NotI and ligated together. To aid purification, His×8 
encoding primers, N43 and N44, were annealed and introduced in front of the YFP 





TagRFP-T was PCR amplified from the pcDNA3-TagRFP-T plasmid using primers 
N48 and N49, cut by PvuI and SalI, and ligated with pNICE-H8-YFP-NL1-AP that 
had been digested with the same restriction enzymes, resulting in pNICE-H8-RFP-
NL1-AP (encoding R-NL1).  
 
2.2.4. NL1-R 
First, we replaced the GPI tag of pNICE-HA-H6-NL1-GPI with a new GS linker 
containing additional cloning sites, PvuI and SalI, and AP tag 
(PHLHNLDI639GGGSGGGSEGGGSGGGSGGGSEG-RS(PvuI)GVD(SalI)-
(AP)). The GS linker was synthesized using primers N38, N39, N50 and N41 by 
staggered PCR, cut by KpnI and NotI, and ligated with pNICE-HA-H6-NL1-GPI 
that had been cut by KpnI and NotI, yielding pNICE-HA-H6-NL1-GS-PS-AP. The 
TagRFP-T PCR product obtained from primers N48 and N49 and pNICE-HA-H6-
NL1-GS-PS-AP were then digested with PvuI and SalI, followed by a ligation to 
give pNICE-HA-H6-NL1-H8-RFP-AP (encoding NL1-R). 
 
2.2.5. NL2-R 
NL2 was amplified from pNICE-HA-NL2 using primers N55 and N56. The GS 
linker was PCR amplified from pNICE-HA-H6-NL1-H8-RFP-AP using primers 
N103 and N104. The pNICE-HA-H6-NL1-H8-RFP-AP was but by BamH I and SalI 




Ectodomain of Slitrk3 was copied from pGW1-Slitrk3 using primers N83 and N74-
2 and cut by HindIII and KpnI. The GS linker fused with H8-RFP, 
GT(KpnI)GSGGGSEGGGSGGGSGGGSEG-RS(PvuI)-(H8-RFP)-VD(SalI)-(AP), 
was PCR copied from pNICE-HA-H6-NL1-H8-RFP-AP using N38-2 and N41 and 
cut by KpnI and NotI. The pNICE-HA-H6-NL1-GS-AP was cut by HindIII and NotI 
and served as a vector for three-piece ligation, finally giving pNICE-SL3-H8-RFP-
AP encoding SL3-R. To screen linker sequences, pNICE-SL3-H8-RFP-AP was 
cleaved by KpnI and PvuI where other linkers with various lengths were inserted. 
The active SL-R was obtained using annealed primers N106 and N107, yielding 
GT(KpnI)GSGGGSEGRS(PvuI)-(H8-RFP)-VD(SalI)-(AP). 
Bicistronic synaptic encoding of postsynaptic CAMs and BirA: To make a 
bicistronic expression vector that allows a simultaneous expression of BirA-ER with 
the postsynaptic CAMs, the internal ribosome entry site (IRES) followed by BirA-
ER gene was introduced (Figure 21). The pNICE-(HA-H6)-CAM-H8-RFP-AP 
(CAM = ectodomain of NL1, NL2, or Slitrk3) were cleaved by NotI to insert IRES-
BirA that was amplified from pAd:CMV-rtTA-IRES-BirA using primers N86 and 
N87 and cut by NotI, generating pNICE-CAM-RAP-BirA after ligation.   
Bacterial expression and purification of bacterial BirA biotin ligase was 
conducted using pET21a-BirA plasmid. The major primers used in this study are 




Table 5. Primers used for the generation of protein NL1-R. Sequences underlined 
are crossover area for the staggered PCR. 




N38-2_KpnI-GS-F ggcggt GGTACCGGCAGCGGCGGAGGCAGCGAGGG 
(35) 
N39_AP-2R      GCCCTCGCTGCCGCCTCCGCTGCCGCCTCCGCTGCC
TCCGCCCTCGCTGCCTCCGCCGCT (60) 




N50_AP-PvuI-SalI-3F     GCGGAGGCGGCAGCGAGGGCCGATCGGGTGTCGA
CGGCCTGAACGACATCTTCGAGGCCC (60) 
N43_H8-PvuI-F  CGCACCATCACCACCACCACCATCACCGAT (30) 





N48_EK-SalI-R   gccaccGTCGACCTTGTCGTCGTCGTCCTTGTACAGCT
CGTCCATGC (47) 
N55_NL2-BamHI-F GTGTGGTCCACAGG GGATCC (20) 













N104_SalI-AP-R CGAAGATGTCGTTCAGGCCG (20) 
N106_SL3-shortGS-F CGGCAGCGGCGGAGGCAGCGAGGGCCGAT (29) 





2.3. Stable cell lines 
For the initial screening of synaptogenic activity of NL1 ectodomains, 24 μg of each 
NL1-encoding plasmid DNA (pNICE-H8-YFP-NL1-AP, pNICE-H8-RFP-NL1-AP, 
and pNICE-HA-H6-NL1-H8-RFP-AP) was added to the 1.5 mL of Opti-MEM I 
Reduced Serum Media. Likewise, 60 μl of 1.0 mg/mL PEI solution was added to the 
1.5 mL of Opti-MEM solution. After 5 min incubation at 25 °C, the two solutions 
were mixed at room temperature for 30 min and added to HEK293 cells grown to 
~20% confluence in a culture dish of 10 cm diameter at 37 °C. The DMEM medium 
was replaced after 4 h incubation. After three days, the cells were treated with G418 
with final concentration of 0.8 mg/mL. The G418 treatment was repeated with fresh 
medium after two days. After two weeks, single colonies with brightest fluorescence 
signals were picked and seeded on a 24-well plate. Among them, the best fluorescent 
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colonies were repeatedly selected until only one colony was left and seeded on a 
culture dish of 10 cm diameter for the subsequent passage. The established stable 
cell line was kept in DMEM medium containing 100 μg/mL G418. 
 
2.4. Preparation of biotinylated synaptic CAMs 
Plasmid pDisplay-BirA-ER (24 μg) in 1.5 mL of Opti-MEM solution was mixed 
with 1.5 mL of Opti-MEM solution containing 60 μg of PEI for 20 min at 25 °C. The 
mixture was added to the established HEK293-H stable cell lines at ~20% confluence 
in a culture dish of 10 cm diameter. After 4 h incubation, the DMEM medium was 
replaced with a fresh one containing 100 μg/mL G418 and 10 μM biotin. The in vivo 
biotinylated synaptic CAM was allowed to secrete into culture medium for three 
days at 37 °C. Then, 10 mL of the medium was saved and the whole cells were 
transferred to a culture dish of 15 cm diameter and filled with 30 mL of DMEM 
containing 100 μg/mL G418 and 10 μM biotin. After another three days, the culture 
media were combined and subjected to column purification using 2 mL of Ni-NTA 
resin according to the manufacturer’s protocol. The three 1 mL elution fractions were 
subjected to fluorescence analysis using Synergy Mx fluorescence microplate reader 
(BioTek, Seoul, Korea). 
For in vitro biotinylation, the stable cell line was grown without BirA 
transfection. To the 1 mL of column elution fraction showing the highest 
fluorescence signal was added 5 mM MgCl2, 1 mM ATP, 0.1 mM biotin, and 30 nM 
BirA enzyme as final concentration and shake incubated for 2 h at 37 °C. The level 
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of in vivo and in vitro biotinylation was analysed via western blot using streptavidin-
HRP or using goat or mouse anti-NL1 antibody and HRP-conjugated secondary 
antibody. The purity of NL1 was analysed by SDS-PAGE with silver staining 
 
2.5. Immunocytochemistry 
Cells were fixed using formaldehyde (4%) for 25 min and rinsed three times with 
PBS (100 mM, pH 7.4). The cells were then incubated in blocking solution (PBS 
containing 4% BSA and 0.1% Triton X-100) for 30 min, followed by incubation in 
primary antibodies diluted in TBS (Tris-buffered saline, pH 7.4) containing BSA 
(0.5%) and Triton X-100 (0.1%) overnight at 4°C. The samples were then washed 
three times with TBS and the fluorescent secondary antibodies were applied for 1 h 
at room temperature in TBS containing BSA (0.5%). The samples were washed 
again three times with TBS and once with DDW, and stored in VECTASHIED 
Mounting Medium with DAPI at -80°C until microscopic examination. Fluorescence 
images were taken with a Zeiss LSM710 confocal laser scanning microscope 
equipped with ZEN 2009 software at the National Center for Inter-university 








3. Results and Discussion 
 
3.1. Construction of labelled NL1 ectodomains 
To generate type-specific artificial dendrites, ectodomains of NL1 (48-639), NL2 
(15-614), and Slitrk3 (28-649) were exerpted from their full sequences (Scheme 5). 
NL1 ectodomain was determined by the crystal structure of NL1/Nrx-1β complex 
that reveals Leu636 as the end of the α-helix required for NL1 dimerization [120, 
132]. Indeed, NL1 (46-638) was the minimum domain functionally secreted to the 
culture medium, whereas NL1 (46-626) and NL1 (46-633) were not [133]. 
Intriguingly, the functional GPI-anchored NL1 contains Leu48-Pro631 [117, 125, 
134], lacking several C-terminal amino acids required for the formation of α-helix 
bundle. Since the GPI motif linked to NL1 (48-631) begins with KLLSATA that has 
high α-helical propensity [135], the overall dimeric structure of GPI-anchored NL1 
may have remained unaltered despite the absence of 631-638 helical residues. 
Ectodomain of NL2 (15-614) was determined by sequence homology with NL1. The 
border of Slitrk3 ectodomain was conservatively set further away from the C-
terminal Leu-rich repeat domain (LRR-CT), seven residues before the 






Scheme 6iii. (a) Schematic structure of artificial synapse displaying postsynaptic 
NL1 homodimer (NL1-R), NL2 homodimer (NL2-R), and Slitrk3 (SL3-R). The 
                                           
iii Dr. Inseong Hwang contributed to this scheme. 
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structures were modeled after NL1 (PDB ID, 3BIX) [120] and NL2 (PDB ID, 3BL8) 
[136], while the structure of Slitrk3 (27-627 residues) was predicted using Slitrk1 
(PDB ID, 4RCW)[137] as a template by the RaptorX server [138], showing two 
LRR1 and LRR2 domains. (b) Schematic structures of engineered synaptic CAMs 
used in this study in comparison to wild type NL1 (WT). (c) Predicted structure of 
NL1-R-Nrx1β complex. The C-terminal tagging module for ectodomain of 




To facilitate massive production, purification, quantification, and localization of 
the ectodomains as well as immobilization of the ectodomains on solid supports, we 
further engineered the NL1 ectodomain, seeking a general tagging module that can 
be applied to the other synaptic CAM molecules. On the basis of previous studies 
showing that both N-terminally YFP-tagged full-length NL1 [139] and 
glycosylphosphatidylinositol (GPI)-linked NL1 ectodomain [117, 125, 129] are able 
to instruct excitatory presynaptic differentiation, we first generated N-terminally 
YFP-tagged and C-terminally GPI-anchored NL1 (Y-NL1-GPI). Unfortunately, the 
purification yield of the Y-NL1-GPI was extremely low, making us replace the GPI-
anchoring motif with AP, a biotin acceptor peptide [140], yielding C-terminally 
biotinylated Y-NL1. To prevent possible dimerization of YFP, we replaced YFP with 
TagRFP-T, a photostable monomeric red fluorescence protein (RFP) [141], to 
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generate R-NL1. We also moved the fluorescence tag from N-terminus to C-
terminus of NL1 ectodomain, while keeping the AP-tag at the ultimate C-terminal 
end of the engineered protein, yielding NL1-R.  
The in vivo biotinylation was further simplified by bicistronic expression of ER-




Figure 21iv. Genetic engineering of postsynaptic CAMs for facile mass production 
with in vivo biotinylation. SS, signal sequence; HA, hemagglutinin affinity tag; H6, 
hexa-His tag; GS, Gly-Ser rich linker; H8, octa-His tag; AP, biotin acceptor peptide; 
IRES, internal ribosome entry site. The SS, HA and H6 vary depending upon the 
type of the postsynaptic CAMs 
 
 
3.2. Generation of stable cell lines 
In order to make a stable cell line, the appropriate cell line and antibiotics must be 
selected. G418 is an antibiotic that is widely used to produce genetically engineered 
                                           
iv Dr. Inseong Hwang contributed to this figure. 
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proteins in mammalian cells, and HEK-293T cells are resistant to G418. Thus, we 
selected HEK-293H cells to perform the viability assay using G418. Figure 25 shows 
a DIC image that demonstrates viability over time in an 800 μg/ml concentration of 
G418. HEK-293H cells, which are adherent cells, grew well at first, while they were 




Figure 22. HEK-293H cell viability assay in 800 μg/ml G418 for (a) 0, (b), 1, (c) 2, 
(d) 3, (e) 5, (f) 7 days. 
 
 
Next, we optimized the conditions for transient transfection. As shown in Figure 
25, green fluorescent protein (GFP) was expressed in HEK-293H cells using either 
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calcium phosphate, lipofectamine 2000, or polyethyleneimine. The experimental 
results showed that the best transfection efficiency was obtained using 
polyethyleneimine (Figure 23c). The highest fluorescence levels were seen after 72 
hours, and this became reduced at 100 hours after transfection, due to GFP gene 
deletion. Thus, we added G418 to the culture media on the third day after transfection 




Figure 23. Optimization of transfection methods for a HEK-293H cell line. 
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Fluorescent images of GFP-transfected HEK-293H cells in three independent 
transfection experiments. (a) Calcium phosphate, (b) Lipofectamine 2000, (c) 
Polyethyleneimine. 
Figure 24 shows the transfection and selection results using the aforementioned 
conditions. It also shows the results of selection over time via fluorescence (Figure 
24a-c), and a single colony whose size was 0.5–1 mm (Figure 24d). We monitored 
expression, purification, and immobilization by tagging fluorescent proteins at the 
synaptic CAMs. It took at least 2 weeks to generate a stable cell line from G418-
treated HEK-293H cells. Two to four weeks after transfection, a selected cell had 




Figure 24. (a) 4, (b) 9 and (c) 12 days after transfection. (d) DIC image of a single 





After identifying a colony that was the appropriate size and that displayed bright 
fluorescence, it was picked using a micropipette on a fluorescence microscope and 
seeded into a 24-well plate. The established stable cell line was sub-cultured in the 
presence of 100 μg/mL G418 in a 10 cm-diameter culture dish (Figure 25). Each of 
the synaptic CAMs were well expressed, as verified by fluorescence. Synaptic 




Figure 25. Merged fluorescence and DIC images of stable cell lines in which 
synaptic CAMs of (a) Y-NL1-G, (b) Y-NL1, (c) R-NL1, (d) NL1-R, (e) NL2-R, and 
(f) SL3-R were expressed.  
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3.3. Purification of synaptic CAMs 
We employed biotin-streptavidin binding as a strategy to attach the synaptic CAMs 
to the solid surface. Two methods for binding biotin to synaptic CAMs are in vivo 
biotinylation, which expresses the BirA enzyme inside cells via transfection, and in 
vitro biotinylation, which uses the BirA enzyme in purified synaptic CAMs. The 
former purifies secreted biotin-conjugated synaptic CAMs by transfecting ER-
specific BirA plasmid into the stable cell line, while the latter purifies secreted 
synaptic CAMs in the stable cell line to perform additional biotinylation. Culture 
media containing synaptic CAMs were subjected to column purification using 2 mL 
of Ni-NTA resin according to the manufacturer’s protocol. Western blotting (Figure 
26) verified that the NL1 derivatives band was successfully purified.  
Quantification of the purified synaptic CAMs was verified by silver staining, 
western blot, and fluorescence intensity. A known amount of BSA was loaded and 
compared with a known volume of the synaptic CAMs elution fraction to yield the 
synaptic CAMs concentration (Figure 27). However, despite successful 
experimental results from in vivo and in vitro biotinylation of synaptic CAMs, those 
that were generated by in vitro biotinylation did not induce an artificial synapse. 
Thus, synaptic CAMs were attached to the streptavidin-coated dynabeads using the 
in vivo biotinylation method to induce an artificial synapse. Figure 30 shows the 
fluorescence image of NL1-R immobilized dynabeads. Since RFP is included, as 
shown in (Figure 30b), red fluorescence was observed in addition to the shape of the 
bead. However, RFP fluorescence was disappeared during the 
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Figure 26. Western blot profiles for the partially purified and labeled NL1s. The 
YFP-tagged NL1-GPI (Y-NL1-G) rarely appeared in the elution fraction despite its 
presence in the total cell lysate. When the GPI motif was replaced with AP, the YFP-
NL1-AP (Y-NL1) was secreted into the culture medium, and was retained in a Ni-
NTA resin. Both in vitro and in vivo biotinylation revealed biotinylated NL1 
regardless of the position of the fluorescence protein. Y-NL1-G was probed by anti-







Figure 27. Partially purified NL1-R was quantified using BSA standards. The 
biotinylated band was verified using western blot (right panel). The relationship 
between fluorescence intensity and concentration of NL1-R was determined to be 












Figure 28. Purified biotin tagged NL1-R was immobilized on streptavidin contained 
2.8 μm Dynabeads. (a) DIC image, (b) Fluorescence image. Since RFP is included, 




3.4. Identification of induced artificial synapse 
We then compared the synaptogenic activity of the engineered NL1 ectodomains by 
incubating them with DIV16 cultured neuronal cells for 24 h followed by 
immunocytochemistry (ICC) to identify immunopositive beads where synapsin I, a 
representative synaptic marker protein, was prominently clustered as a result of the 






Figure 29v. NL1-R induces artificial synapse independently of SLB membrane. 
NL1-R has the strongest synaptogenic activity streptavidin coated Dynabeads when 
incubated with DIV14 hippocampal neuron culture for 2 days. Synapsin I (Syn I) 
aggregation were induced by NL1-R on streptavidin coated Dynabeads. Scale bars 
= 10 μm.  
 
 
The dynabeads (Figure 29, left, upper images) to which each of the biotinylated 
NLs derivatives was fixed formed an artificial synapse by joining with randomly 
cultured hippocampal neurons. We found that although the N-terminally YFP-tagged 
NL1 was proven to have synaptogenic activity, biotin-tagged Y-NL1 was barely 
                                           
v Eun Joong Kim contributed to this experiment. 
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functional compared to NL1-R when immobilized on the dynabeads. On the other 
hand, we observed that strong fluorescence was emitted by the C-terminally RFP-
tagged NL1 on the microspheres and the most robust artificial synapse was induced. 
This indicated that the structural difference was important because synapses were 
induced through pairing with Nrxs even when the other components were the same. 
Furthermore, we separated and purified not only NL1 derivatives that induced an 
excitatory synapse but also NL2-R and SL3-R that induced an inhibitory synapse 
using the same experimental procedure, thereby verifying that an artificial synapse 
















4. Conclusion and Perspective 
 
We have demonstrated the feasibility of engineered synaptic CAMs for the induction 
of artificial synapses. The synaptic CAMs can easily be biotinylated in vivo, purified, 
and quantified from their initial production to the final assay steps. The NL1 
ectodomain allows C-terminal tagging for optical tracking and surface 
immobilization that dispenses with lipid bilayers for its synaptogenic activity. 
Removal of the lipid bilayer on inorganic substrates can greatly reduce the 
complexity and workload for establishing artificial synapses. This biased preference 
to a specific type of synapse induced by synaptic CAMs, if combined with other 
neuroengineering techniques such as micro- and nano-architectures for neural 
stimulation and recording, will provide unique possibilities for novel artificial neural 
interfaces. Moreover, this method will be used as the basis for studying the 
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고체상 추출은 시료를 전처리 하는 방법의 하나로 분석 분야에서는 복잡
한 미지시료에서 관심 종을 분석하기 위한 분리, 농축 및 정제의 수단으
로 사용되며, 최근에는 생체 모사 표면 공학을 통해 결합 친화성을 높이
고 민감도와 선택성을 증가시키려는 노력들이 진행되고 있다. 혈액과 세
포와 같은 복잡한 생체시료를 분석하기 위해서는 고체상 표면과 관심 종
과의 물리/화학적 상호작용이 매우 중요하며, 관심 분석물질이 고체표면
에 직접적으로 상호작용하는 유형과 세포와 같은 분석대상을 표면에 도
입하여 분비되는 물질을 관찰하는 유형으로 구분할 수 있다. 본 학위 논
문은 (i) 향상된 분석물질-고체표면 상호작용을 위한 생체 영감 표면 
수식화 와 (ii) 인공시냅스 유도와 생분석을 위한 신경 세포 부착 단백
질 정제의 응용사례를 보고했다. 
 
파트1. 분석물질-고체 표면 상호작용: 향상된 면역분석법을 위한 생체 
모사 건축물을 가진 바이러스로 꾸며진 자성 금 마이크로쉘 
 
섬사상 파지 바이러스는 세포의 기능을 높이는 많은 가늘고 긴 구조와 
유사한 구조적 차원들을 가지고 있다. 이 연구의 목적은 생물체의 시스
템을 닮은 바이러스와 마이크로 입자의 결합이며, 그렇게 함으로써 독특
한 형태에서 유래된 증가요소가 있다. 우리는 자기조립분자층을 형성하
기 위해 마이크로 쉘 위에 금 층을 형성하고 이는 스트렙타아비딘을 사
용한 화학조작과 비특이적 흡착을 방지하는데 도움이 된다. 파지 비리온
들은 스트렙타아비딘으로 개질 된 금 마이크로쉘에 선택적으로 결합하기 
위해 그들의 꼬리에 바이오틴이 결합되어 있다. 우리는 표면 대 부피 비
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율 증가로 인해 바이러스 개질 된 금 마이크로쉘 위에 고정되는 항체의 
양이 증가되는 것을 확인했다. 실제로 카디악 트로포닌I 와 마이오글로
빈 각각이 검출되는 민감도가 증가했다. 이 연구는 바이러스와 비 생체
물질의 결합이 정량분석 가능한 향상된 면역분석을 위한 생체모방 수단
이 될 가능성을 설명하고 있다. 
 
파트2. 세포-고체 표면 상호작용: 인공 시냅스 유도를 위한 신경 세포 
부착 물질 정제 
 
전통적인 신경 인터페이스는 오로지 신경세포와 비 생물체의 수동적인 
물리적 접촉에 의존한다. 하지만 뇌에서의 신경세포는 시·공간상의 특수
함이 정교하게 조절된 시냅스를 통해 의사소통 한다. 이 시점에 우리는 
새롭게 조작된 형광과 바이오틴이 붙어 정제, 정량, 추적, 무기 기질 위
에 고정이 가능하게 하는 시냅스 후 세포 부착 물질을 보고한다. 방향성
이 조절된 고정으로부터 유래된 지질 막 위의 시냅스 후 세포 부착 물질
의 독립성은 신경세포와 다양한 무기 고체 기질간에 인공 시냅스 형성에 
맞게 단백질의 기능성을 확장한다. 또한 세포와 고체 표면과의 상호작용
을 연구하기 위한 기초로 활용될 것이다. 
 
주요어: 골드 마이크로쉘, 서스펜션 어레이, 비특이적 흡착, 바이러스, 
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Solid-phase extraction (SPE) is a sample preparation method used as a means of 
separation, concentration, and purification for analysis of complex unknown samples 
in the analytical field. Recently, there have been efforts to increase binding affinity, 
sensitivity, and selectivity through biomimetic surface engineering. In the analysis 
of complex biological samples, like blood and cells, physical and chemical 
interactions between the solid-phase surface and target species are crucial. These 
interactions can be divided into those in which the target analyte directly interacts 
with the solid surface and those in which the secreted substance is observed upon the 
introduction of target analyte, including cells, to the surface. This dissertation 
 
ii 
describes (i) bio-inspired surface modifications for enhanced analyte-solid surface 
interactions and (ii) the purification of synaptic cell adhesion proteins for induced 
artificial synapses and bioanalysis. 
 
Part I. Analyte-solid surface interaction: virus-decorated magnetic gold 
microshells with biomimetic architectures for enhanced immunoassays 
 
Filamentous phage virus has similar structural dimensions to many cellular 
threadlike structures that enhance the cellular functions. The aim of this study was 
to combine the virus and microshells to resemble biological systems, thereby 
harnessing the enhancement factors originating from the unique morphology. We 
implemented gold layer on a microshell to form a self-assembled monolayer that 
help with chemical modifications using streptavidin and protection from non-
specific adsorptions. Phage virions that carry biotins within their tails were prepared 
for directional binding of the virions to streptavidin-modified gold microshells. We 
confirmed the augmented yield of antibody loading on virus-modified gold 
microshells because of the increased surface to volume ratio. Indeed, the sensitivity 
has increased up to nine-fold for the detection of cardiac marker proteins. This work 
demonstrates the feasibility of merging viruses with non-biological substrates to 





Part II. Cell-solid surface interaction: purified synaptic cell adhesion 
molecules for induced artificial synapse 
 
Conventional neural interfaces solely depend upon passive physical contact 
between nerve cells and their non-biological counterparts. Nerve cells in the brain, 
however, communicate via synapses of which spatiotemporal specificity is 
exquisitely regulated. Here, we report a newly engineered postsynaptic cell adhesion 
molecules (CAMs) that are fluorescent and biotinylated to facilitate its purification, 
quantification, tracking, and immobilization on inorganic substrates. The 
independence of synaptic CAMs on the lipid membranes, originating from the 
orientation-controlled immobilization, extends versatility of the protein to fit in 
artificial synapse formation between neurons and various types of inorganic solid 
substrates. Moreover, this method will be used as the basis for studying the 
interaction between the cell and solid surface. 
 
Keywords: gold microshell, suspension array, non-specific binding, virus, artificial 
synapse, neuroligin, synaptic cell adhesion molecules 


























Abstract .......................................................................................................................... i 
 
Contents ......................................................................................................................... v 
 
List of Figures .............................................................................................................. ix 
 
List of Schemes and Tables ......................................................................................... xv 
 
 
PART 1. Analyte-solid surface interaction: virus-decorated magnetic gold 
microshells with biomimetic architectures for enhanced immunoassay 
 
1. Background and Overview ........................................................................................ 3 
 
1.1. Immunoassay .......................................................................................................... 3 
 
1.2. Planar array and suspension array .......................................................................... 5 
 
1.3. Microspheres .......................................................................................................... 8 
 
1.4. Virus ..................................................................................................................... 14 
 
1.5. Purpose of this work ............................................................................................. 18 
 
2. Introduction ................................................................................................................. 19 
 
3. Experimental Methods .............................................................................................. 23 
 
3.1. Reagents ............................................................................................................... 23 
 




3.3. Field-Emission Scanning Electron Microscopy (FE-SEM) .................................. 24 
 
3.4. N-SIM super resolution microscopy ..................................................................... 25 
 
3.5. Production of BirA ............................................................................................... 25 
 
3.6. Production of phage carrying biotinylation motif ................................................. 26 
 
3.7. Biotinylation of phages ......................................................................................... 26 
 
3.8. Surface modificatyions of gold microspheres ...................................................... 27 
 
3.9. Optimization of phage loding onto gold microspheres ......................................... 27 
 
3.10. Optimization of staudinger ligation .................................................................... 27 
 
3.11. Cardiac marker assay .......................................................................................... 28 
 
4. Results and Discussion .............................................................................................. 30 
 
4.1. Characterization of magnetic gold microshells .................................................... 30 
 
4.1.1. Physical and chemical stability test of gold microshells ............................ 32 
 
4.1.2. Protein immobilization of gold microshells ............................................... 36 
 
4.1.3. Sandwich immunoassay of antibody decorated gold microshells .............. 42 
 
4.2. Preparation and characterization of engineered phage virions ............................. 44 
 
4.3. Evaluation and optimization of virus decorated gold microshells ........................ 47 
 
4.4. Visualization of virus decorated gold microshells ................................................ 49 
 
4.5. Optimization of staudinger ligation ...................................................................... 53 
 




5. Conclusion and perspective ..................................................................................... 60 
 
 
PART 2. Cell-solid surface interaction: purified synaptic cell adhesion 
molecules for induced artificial synapse 
 
1. Introduction ................................................................................................................. 63 
 
2. Experimental Methodsers ........................................................................................ 69 
 
2.1. Materials ............................................................................................................... 69 
 
2.2. Molecular biology ................................................................................................ 70 
 
2.2.1. Y-NL1-G .................................................................................................... 70 
 
2.2.2. Y-NL1 ........................................................................................................ 70 
 
2.2.3. R-NL1 ........................................................................................................ 71 
 
2.2.4. NL1-R ........................................................................................................ 71 
 
2.2.5. NL2-R ........................................................................................................ 71 
 
2.2.6. SL3-R ........................................................................................................ 72 
 
2.3. Stable cell lines ..................................................................................................... 74 
 
2.4. Preparation of biotinylated synaptic CAMs.......................................................... 75 
 
2.5. Immunocytochemistry .......................................................................................... 76 
 
3. Results and Discussion .............................................................................................. 77 
 




3.2. Generation of stable cell lines .............................................................................. 80 
 
3.3. Purification of Synaptic CAMs ............................................................................ 85 
 
3.4. Identification of induced artificial synapse ........................................................... 88 
 
4. Conclusions and Perspectives ....................................................................................... 91 
 
 
References .......................................................................................................................... 93 
 
 
List of Publications .......................................................................................................... 105 
 
 





















List of Figures 
 
Figure 1. Number of papers published in each year between 1985 and 2014 in 
which terms microsphere and/or microspheres were used, according to the ISI 
Web of Knowledge scientific base search. 
Figure 2. Structure of filamentous phage (M13 or fd) and the genetically 
engineered version. The phage DNA is encased in a capside made of four minor 
coat proteins (pIII, pIX, pVI, and pVII) located at one of the two distal ends of the 
phage and one major coat protein (pVIII), several thousand copies of which 
constitute the side wall of the phage. The landscape phaeg library was pioneered by 
V. A. Petrenko and G. P. Smith (adapted from reference [66]). 
Figure 3. (a) SEM image of iron oxide-embedded 15 μm magnetic gold microshells. 
TEM images of magnetic gold microshells (b) and (c). As shown in (c), the thin gold 
layer was less than 200 nm thick. 
Figure 4. Solvent test of gold microspheres. SEM images of gold microshells that 
were put into (a) PBS buffer, (b) ethanol, (c) dimethyl sulfoxide, (d) N,N-
dimethylformamide, or (e) 1,4-dioxane, followed by 30 minutes of sonication and a 
16 h incubation at 25 °C. 
Figure 5. (a) Optical image of the gold microshell before the SAMs were formed (b) 
Optical image of the gold microshell after the SAMs were formed (c) Dispersion 
state in the solution after the SAMs were formed (d) Image at 30 seconds after a 
 
x 
magnet was placed beside the tube. 
Figure 6.  Verification of the stability of SAM-modified gold microshells. SAM-
protected gold microshells were incubated in phosphate-buffered saline (PBS) buffer 
at (a) 4 °C or (b) 25 °C for 24 hours. Each of (a) and (b) samples was incubated at 
4 °C , 25 °C , 40 °C for 24 hours and then treated with streptavidin and biocytin-
alexa594 for 1 hour at 25 °C to observe fluorescence. Biocytin-Alexa Fluor 594 dye 
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treated with BirA, followed by western blot visualized using streptavidin-HRP. (c) 
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Figure 24. (a) 4, (b) 9 and (c) 12 days after transfection. (d) DIC image of a single 
colony in which G418 selected NL1-R was expressed two weeks after transfection. 
Figure 25. Merged fluorescence and DIC images of stable cell lines in which 
synaptic CAMs of (a) Y-NL1-G, (b) Y-NL1, (c) R-NL1, (d) NL1-R, (e) NL2-R, 
and (f) SL3-R were expressed. 
Figure 26. Western blot profiles for the partially purified and labeled NL1s. The 
YFP-tagged NL1-GPI (Y-NL1-G) rarely appeared in the elution fraction despite its 
presence in the total cell lysate. When the GPI motif was replaced with AP, the YFP-
NL1-AP (Y-NL1) was secreted into the culture medium, and was retained in a Ni-
NTA resin. Both in vitro and in vivo biotinylation revealed biotinylated NL1 
 
xiv 
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1. Background and Overview 
 
1.1. Immunoassay 
The first immunoassay was developed by Landsteiner in 1954, who detected small 
molecules called “haptens” using antibodies [1]. In 1971, E. Engvall and P. Perlmann 
introduced enzyme-linked immunoassay [2], which is now known as the 
representative enzyme-linked immune-sorbent assay (ELISA); it is used to observe 
color changes using antibodies. Such immunoassays are widely used as quantitative 
methods for detecting supramolecules (e.g., cells, proteins, and polypeptides) and 
small molecules (lipids, hormones, chemicals, etc.) in various fields of molecular 
biology and environmental science. Color changes of substrates such as 
tetramethylbenzidine (TMB) and p-nitrophenyl phosphate (p-NPP) following 
reaction with antibodies were observed in traditional ELISA, but recently, ELISA-
like technologies that do not use enzymes, but use a new reporter that generates 
various signals, have been widely adopted [3-10]. 
Immunoassays are categorized into optical and non-optical methods 
(electrochemical, mass sensitive, calorimetric) depending on the transducing 
mechanism. Optical immunoassay can be classified into the following 6 types: 1. 
UV/VIS spectroscopy, which measures the optical or electronic properties of a 
material, such as absorption, transmission, and reflectivity; 2. fluorescence, which 
measures the shift in the wavelength of the fluorophore, time dependence of 
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fluorescence emission, and energy transfer phenomena; 3. surface plasmon 
resonance, which measures the changes in wavelength, intensity, and the phase or 
angle of incidence; 4. chemiluminescence, which measures characteristic light from 
a reaction product prepared by oxidation of a luminol reactant; 5. Raman 
spectroscopy, which measures vibrational energy states; and 6. Interferometry, 
which measure the changes in the evanescent field. The optical immunoassay has the 
advantages of high sensitivity and high speed and benefit from developing 
infrastructure. Especially, as the fluorescence immunoassay method does not require 
additional substrate (TMB, p-NPP, luminol) is being widely used. The fluorescence 
immunoassay can be carried out by one of two methods: by conjugating the 
fluorophore or the quantum dot to the antibody. Of these two, the fluorophore-based 
method is widely used. 
The representative advantage of immunoassay over other binding assays is its 
low detection limit and high analyte selectivity. On the other hand, its representative 
disadvantages are that it is greatly influenced by antibody activity and its cross 
reactivity with the structural analogs of the target analyte [11]. As indicated by Prof. 
B. M. Spiegelman [12] and Prof. A. J. Wagers [13], immunoassays using antibodies 
have become controversial, so much so that an article named 'Blame it on the 
antibodies' was published in Nature 2015. Although errors due to incorrect molecular 
recognition may arise with use of antibodies in immunoassays, no other substitute 
binding has been developed, and the immunoassay remains one of the preferred 
methods for biological sample analysis [14]. 
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1.2. Planar array and suspension array 
The quality and average expectancy of human life have increased with rapid 
advancements of modern science. In terms of disease diagnosis, specific test items 
have also increased with the advancement of science and technology. For example, 
there are over 200 test items (Table 1), including chemicals, DNA, lipid protein, and 
cells in a blood test [15], and early diagnosis is critical for disease 
prevention/treatment [16, 17].  
 
Table 1. Sorted by category of blood analysis 
 category # of test 
1 Ions and trace metals 17 
2 Acid-base and blood gases 9 
3 Liver function 9 
4 Cardiac marker 9 
5 Lipids 6 
6 Tumour markers 9 
7 Endocrinology 29 
8 Vitamins 8 
9 Toxins 2 
10 Hematology 31 
11 Immunology 25 
12 Other enzymes and proteins 7 
13 Other electrolytes and metabolites 12 
 
 
Rapid, accurate, low-cost, and efficient detection and quantification of various 
disease markers from a limited amount of samples is the hot topic of interest in 
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analytical chemistry. The conventional immunoassay format of ELISA requires 
about 500 ng of capture antibody and 50~100 µL of a sample to analyze one 
specimen. As a result, an array type binding assay technology has been developed as 
a miniaturized, parallel binding assay for multiplexed detection [18]. The first 
multiplexed immunoassay was developed by L. G. Feinberg in 1961 for microspot 
test of antibody-antigen reaction in the thin agar films on the cover glass [19]. Since 
then, various attempts have been made, but the main approach can be divided into 2 
general methods: the use of 2D planar micro arrays or 3D suspension array. 
A 2D planar array is an assay that captures molecules immobilized in 
microspots (diameter < 250 µm), with several thousand spots exist per square 
centimeter [20]. The individual microspots are located hundreds of micrometers 
apart to prevent mutual contamination, and may immobilize different capture 
molecules. DNA chip and Protein chip are examples of 2D planar arrays, often 
referred to as a planar array or a microarray [21]. The protocol of a 2D planar array 
is similar to that of conventional ELISA, and generally scans fluorescence or 
chemiluminescent signals. For multiplexed detection, the different capture 
molecules must be located at nearby spots and the array needs to remember the 
immobilized capture molecule at each spot. When the X and Y locations are 
memorized in a 2D planar array for multiplexed detection, it is easier to remember 
the locations of the capture molecules, which is a comparatively easier barcoding 
method than 3D suspension array. 
A 3D suspension array is an analytic system that suspends a few micrometer-
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sized microspheres (particles or beads) of the immobilized capture molecules in a 
solution, and reacts them with an unknown sample to detect the signals from these 
particles. The suspension array has the following advantages over planar array. First, 
the total assay time (TAT) is shorter and a smaller sample volume is required. As the 
Micrometer sized particles have fast diffusion and smaller steric hindrance with their 
high surface to volume ratio, compulsory-mixed by external force is possible. 
Furthermore, a planar array must set adjacent spots apart by a fixed distance to 
prevent their cross contamination, creating a dead surface that consequently 
increases the area contacted by the sample solution. Therefore, the suspension array 
requires shorter total analysis time compared to the planar array, with a smaller 
sample volume. Second, it has greater sensing flexibility with the different capture 
molecules that can be mix-and-matched at different combinational at will. Third, the 
suspension array can replicate each target molecule from hundreds to thousands in 
the single experiment, offering greater reproducibility and high precision 
measurements. Fourth, it is cost-effective because of the reduced TAT and improved 
reproducibility and precision by performing only one experiment [20]. Unlike a 2D 
planar array, a 3D suspension array has suspended micrometer-sized particles that 
move while in solution, requiring barcoding for individual particles. The most widely 
used barcoding method is the optical one, which uses an organic dye [22], quantum 
dots [23], IR [24], or a Raman probe [25]. Chemical [26], graphical [27], electronic 
[28], and physical methods [29] are also used. 
A planar array obtains signals by scanning, but a suspension array obtains 
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information using flow cytometry. Flow cytometry hydrodynamically focuses the 
suspended particles in a solution and passes a beam of light (usually laser light) of 
single wavelength through the suspension for the analysis. Coulter counter and 
fluorescence-activated cell sorter (FACS) are representative analytical methods of 
flow cytometry. Since the first report of flow cytometry in the 1960s, it has been 
used in a variety of areas, and has become an essential technique in the diagnosis of 
health disorders [30]. A conventional Coulter counter or FACS has the disadvantages 
of being expensive and very large. To compensate for these disadvantages, 
microfluidic chip based flow cytometry has been introduced. J. M. Ramsey 
distinguished 1- and 2 μm particles through electrokinetic focusing in a microchip 
and reported a throughput of 34 particles [31]. T. D. Chung et al. distinguished white 
blood cells and red blood cells using a microfluidic chip and direct current (DC) 
impedance [32], and in 2010, developed a microflow-cytometry system that could 
simultaneously detect particle size by DC impedance and fluorescence by laser [33]. 
Recently, a mixed planar array system has been reported, which can lithographically 
build a wall to immobilize the particles while scanning to detect signals [34]. 
 
1.3. Microspheres 
Polymer particles, such as poly(methyl methacrylate) (PMMA), polystyrene (PS), or 
silica particles of 1~100 µm (mostly 2~15 µm) are generally used in 3D suspension 
array systems. Polymer or silica particles are separated by centrifugation, but 
magnetic particles, which encapsulate magnetic pigments such as iron oxide and 
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nickel particles or whose surfaces have been introduced with a magnetic pigment, 
are widely used. Presently, microspheres are moving beyond the academic field 
(Figure 1) of experimentation and are being widely used commercially. These types 
of microspheres are being widely used in clinical diagnostics, molecular 
assays/cellular assays (drug targeting, cell isolation and purification, nucleic acid or 




Figure 1. Number of papers published in each year between 1985 and 2014 in which 
terms microsphere and/or microspheres were used, according to the ISI Web of 





















































Many companies sell microspheres or microsphere-related products. For 
commercially available microspheres, certain beads builders sell naked beads (Table 
2); however, most of the time, they sell surface-functionalized or modified beads, 
while also providing experimentation services (Table 3) [36].  
 
Table 2. List of commercialized beads builders. 
Company Products Location 
Dynal Biotech Inc.  Thermo Polymer Norway 
Merck Estabor  Millipore Polymer/Silica France 
Seradyn Inc. Thermo Polymer USA 
Bnag’s Lab. Polymer/Silica USA 
Luminex Corp. Polymer USA 
Immunico Corp.  
Johnson&Johnson/Veridex 
Polymer/Silica USA 
Spherotech Inc. Polymer/Silica USA 
Advanced Magnetics Inc. Polymer U.K. 
CPG Inc.  Millipore Polymer USA 
Promega Polymer USA 
Ferrofluidics Corp. Polymer USA 
FeRx Inc. Polymer USA 
Miltenyi Biotec Polymer Germany 
PolyMicrospheres Inc. Polymer USA 
Chemicell Polymer/Silica Germany 
 
 
Bangs laboratories, Inc., established in 1988, provides 1–25 μm PS, PMMA, or 
SiO2 particles whose surface have been aminated or caboxylated, or decorated with 
a certain antibody or protein [37]. Dynabeads, widely known as Thermo Fisher 
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Scientific Company, sells various products such as iron oxide type magnetism 
introduced 1, 2.8, 4.5 μm sized PS particles conjugated with glycidyl ether and 
having proteins on their surfaces [38]. The US microspheres-Nanospheres Company 
sells sub-micrometer sized particles of gold, silver, aluminum oxide, titanium oxide, 
silicon oxide and 1–100 μm particles of PS, PMMA, and SiO2, as well as surface-
functionalized products [39]. 
 
Table 3. List of commercialized beads products and services. 
Company Products & Services Location 
Marligen Biosciences Transcription Factors Maryland, USA 
Panomics mRNA, RNAi, Immunoassays California, USA 
Radix BioSolutions Ltd. DNA Hybridization, Immunoassays Texas, USA 
Applied Cytometry Systems Software & Assay Development California, USA 
Bio-Rad Life Science 
Bio-Plex: Instruments, Cytokines, 
Isotyping, etc. 
California, USA 
Cayman Chemical Company 






Eva Technologies Corp. Autoimmunity, Cancer, etc. Alberta, Canada 
Exiqen Gene Expression Denmark 





Allergy Virginia, USA 
Invitrogen 
Cytokines, Signal Transduction, 
Neuroscience, etc. 
California, USA 
Marligen Biosciences, Inc. Genotyping & mRNA Maryland, USA 
Millipore Corp. 
Cytokines, Apoptosis, Cardiac, 
Endocrine, etc. 
Missouri, USA 
MiraiBio Equipment, Software & Materials California, USA 
Novagen Cellular Signaling & Cancer Wisconsin, USA 
Panomics Cellular Signaling, Cytokines, etc. California, USA 









R&D Systems, Inc. Cytokines, MMP’s, etc. Minnesota, USA 
Rules Based Medicine Assay Services Texas, USA 
Wageningen University and 
Research Center 
Plant pathogenic virus The Netherlands 
Abbott Molecular Inc. FISH Illinois, USA 
Asuragen 
Signature, Genetic Testing, 
Oncology 
Texas, USA 
BMD Autoimmune & Infectious Disease France 
Bio-Rad Diagnostics Autoimmune, etc. California, USA 
Celera Diagnostics Infectious Disease &Cystic Fibrosis California, USA 
MiraiBio Equipment, Software & Materials California, USA 
EraGen Biosciences Genetic Analysis Wisconsin, USA 
Fisher Healthcare Prima Texas, USA 
Focus Diagnostics Assay Services California, USA 
INOVA Diagnostics, Inc. Autoimmune Disease California, USA 
ImmuneTech Allergy California, USA 
InnoGenetics NV Neurodegeneration Belgium 
Inverness Medical 
Professional Diagnostics 
Autoimmune Disease New Jersey, USA 
MICROBIONIX GmbH 




Infectious disease, Inflammation, 
Coagulation, etc. 
Germany 
One Lambda, Inc. HTA Testing California, USA 
Tepnel Lifecodes HLA Testing 
Connecticut, 
USA 
Zeus Scientific, Inc. Autoimmune Disease New Jersey, USA 
 
 
The representative company that offers suspension arrays is Luminex Corp., 
established in 1996. They offer not only microspheres but also provide integrated 
support from signal readout devices to experimental services. Various chemical 
functional groups and oligomer or protein can be conjugated to a 5.6 μm size 
polystyrene particle, and 6.5 μm PS particles are used as magnetic microspheres [40]. 
Currently, 500-plex analysis is possible by swelling the polymer microspheres in an 
organic solvent and allowing two organic dyes of different proportions to enter the 
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microspheres, followed by shrinking them in an aqueous solution. Data can be 
acquired by flow cytometry, using the non-overlapping fluorophore wave as the 
target signal, and by barcoding and passing the microspheres through a fixed laser 
pathway. Like Luminex, Affymetrix also offers services related to microspheres that 
allow 100-plexed detection with an internal dye and 4–5 μm sized PS particles as the 
microspheres [41]. Miltenyi Biotec company offers 2, 3 µm microspheres, reagents; 
equipment; and total analysis service for flow cytometry and cell stimulation as a 
Magnetic Activated Cell Sorting (MACS) technology [42]. The Korean company 
Bioneer sells 1–5 μm SiO2-based magnetic microspheres with various surface 
modifications [43]. 
In 2007, T. Nagaoka et al. made gold-coated microspheres on polystyrene and 
reported their applications. They attached gold nanoparticles to 6 µm polystyrene 
particles and plated them by electroless plating to form a gold layer, introducing 
various metal layers, such as nickel, silver and copper, on the polymers for 
application in electronic devices [44]. Furthermore, in 2009, they introduced a gold 
layer on plastic particles using a binder, describing its potential use as an anisotropic 
conductive film (ACF) [45]. M. E. Meyerhoff et al. reported the first instance of 
using magnetic gold microspheres for immunoassay in 2006. They introduced gold 
to 4.5 µm magnetic polystyrene microspheres through electroless plating, and 
covalently attached antibody fragments to a tosyl-activated surface; the absorbance 
signal was detected using alkaline phosphatase and p-NPP [46]. At the same time, 
M. Liu et al. proposed a fluorescence signal analysis system by attaching antibodies 
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after forming a gold layer on 100 μm PS particles [47]. In 2011, an immune-device 
system integrating gold microspheres with immobilized protein using self-assembled 
monolayers, microfluidic chip, and dielectrophoresis was reported [48]. Commercial 
gold microspheres can be purchased from the SEKISUI chemical corp. and the 
Nomadien corp. SEKISUI gold microspheres were developed for electric contact, 
and contain nickel inside with the surface gold layer [49]. Nomadien corp. 
introduced magnetism and a layer of gold on 2–15 μm polymer microspheres, and 
showed their potential use in detecting various biological molecules [50-54]. 
 
1.4 Viruses 
Virus, a contagious particle of size less than a few hundred micrometers, replicates 
only inside the living cells of other organisms, and can be categorized into 
bacteriophages (shortened to phages), plant viruses, and animal viruses depending 
on the host. Early virus-related research was conducted in the fields of molecular and 
cell biology in the broad areas of life sciences and medicine. Recently, viruses have 
been used as chemical and biological sensors in material science and nanotechnology. 
Phages, which are used widely in sensing applications, have the following 
advantages. First is the well-established phage display technology. Phage display is 
a technique that selects the high-binding-affinity sequence by amplifying only the 
target-specific phage from a randomly sequenced phage library [55]. Second, they 
show high sensitivity and selectivity through target-specific recognition, an inherent 
virus function. Third, they exhibit multivalent interactions. A virus is composed of 
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several domain proteins, each domain having about 3000 copies. Therefore, a strong 
multivalence can be obtained if a target domain is given functionality [56, 57]. 
Fourth, they can be mass-produced in a cost-efficient manner in the host bacterial 
cell. Fifth, they have good chemical and thermal stability, allowing them to survive 
in acidic, basic, or non-aqueous media, and at temperatures up to 180 °C. Sixth, they 
can be used as a template for self-assembly of uniform size and shape with a 
nucleation site [58]. 
Phages can be categorized into lytic phages, such as T4 and MS2 phages, which 
replicate in a bacterial cell and leave the host cell after killing it, and non-lytic phages, 
such as M13 and fd phages, which leave the host cell without killing it. The T4 
bacteriophage, which is frequently shown in literature as having a spaceship-shaped 
icosahedral head and tail, has an inner diameter of 55 nm, tail length of 28.5 nm, and 
diameter of 19 nm. The MS2 phage, which looks like a nanosphere, has a diameter 
of 23–27 nm. Fd and M13 phages are nanofiber-shaped with a ~6 nm diameter and 
~1 μm length. Filamentous M13 and fd phages have been the most-preferred 
genetically modified phages since G. P. Smith first introduced the phage display 






Figure 2. Structure of filamentous phage (M13 or fd) and the genetically engineered 
version. The phage DNA is encased in a capside made of four minor coat proteins 
(pIII, pIX, pVI, and pVII) located at one of the two distal ends of the phage and one 
major coat protein (pVIII), several thousand copies of which constitute the side wall 
of the phage. The landscape phaeg library was pioneered by V. A. Petrenko and G. 
P. Smith (adapted from reference [66]). 
 
Of the 5 types of structural proteins that surround the internal single-strand 
DNA of the phages, genetic engineering techniques for the pIII and pVIII proteins 
have been reported most frequently, and two or more proteins can be genetically 
engineered simultaneously (Figure 2). For example, foreign peptides or proteins can 
be expressed in a certain structural protein by inserting the desired DNA sequence 
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in the gene of a phage vector. The yield of the structural protein with multiple copies 
is determined by the size and folding level of the expressed peptide; in general, a 
small peptide gives better expression than a large peptide. 
As the filamentous phages are themselves nanoparticles, much attention has 
been paid not only for their sensing applications in terms of function and shape, but 
also as templates for nanostructure synthesis. They have been used as chemical and 
biological sensors [61] in a form that integrates the inherent target-recognition 
function of phages with the conventional methods of quartz crystal microbalance 
[62-64], ELISA [65-67], and optical [68, 69] and electrochemical methods [70, 71]. 
To use phages as a template to introduce metals or metal oxides, a nucleation site or 
affinity is needed; different combinations have been reported using phage display 
(PD) and cell-surface display (CSD) [72]. A. M. Belcher et al. at Massachusetts 
Institute of Technology conduct active research on the application of phages as a 
template. They reported the potential use of phage-templated nanowires as electrodes 
for lithium-ion batteries in their representative study published in Science in 2006 
[73], with the nanowires made by expressing cobalt- and gold-nucleating motifs on 
phage body. J. N. Cha et al. detected surface-enhanced Raman spectroscopy signals 
after binding DNA-Raman-active nanoparticles to phages and loading the phages on 
silica microbeads [74]. K. T. Nam et al. successfully detected prostate-specific 
antigens using virus-probes, which were made by expressing the gold-binding 
peptide sequence on the phage body, integrating gold nanocubes, and immobilizing 
them on magnetic microbeads [75]. 
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1.5 Purpose of this work 
The major purpose of the current research was to develop a biocompatible and bio-
inspired biosensor with high potential to be used for the improved analyte-solid 
surface interactions. In this work, we will focus on demonstrating the feasibility of 
our phage-decorated three-dimensional suspension array system using cardiac 
marker proteins, cardiac troponin I (cTnI) and myoglobin. While many assay 
systems based on microbeads lack quantitative mode of action, our virus-gold 


















Recent outbreak of virus-based hybrid materials has enabled realization of highly 
selective and sensitive biosensors [58]. The benefits of the merger between virions 
and biosensing materials intuitively originate from the virion’s capability of 
molecular recognition [76-80] and innate physical properties that stem from the 
phenotypic morphologies [81-88]. However, despite the functional advances in 
biosensors using virus hybrids, the detection systems largely remain in two-
dimensional planar platforms, requiring relatively large sample volumes and greater 
time for analysis [58]. 
In this work, we demonstrate enhanced detection of protein biomarkers using 
gold-layered magnetic microspheres on which viral filaments are tethered in 
orientation-controlled manner. The magnetic gold microspheres, like many other 
typical microspheres, are compatible with flow cytometers, fluorescence activated 
cell sorting (FACS) systems, and conventional fluorescence microscopes, requiring 
minute sample volumes, and allowing statistical analysis that raises credibility [89]. 
Importantly, in contrast to nanoparticles, the gold microspheres are eligible for the 
detection of small molecule biomarkers in serum.  
In biosensor development for immunoassays, preventing non-specific 
adsorption while providing high antibody loading is of primary importance. Since 
we had been experiencing a heavy non-specific binding to typical polymer beads 
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when using blood or serum samples, we envisioned that covering the porous and 
sticky surfaces of the polymer beads with gold and thiol self-assembled monolayers 
(SAMs) should resolve the adsorption problem. The SAM molecules, if properly 
chosen, are able to prevent non-specific interactions between gold surface and 
analytes as well as to provide functional groups for protein conjugation [90-92]. 
Filamentous bacteriophages, such as fd and M13, have nanostructured 




Scheme 1i. Schematic representation of the bioinspired virus-gold microsphere. A 
thin gold layer allows facile surface modifications by thiol SAMs followed by 
chemical conjugation of functional proteins, such as streptavidin (streptavidin, 
                                           
i Dr. Inseong Hwang contributed to this scheme. 
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purple). The streptavidin-modified microspheres are decorated with pIII-biotinylated 
phage virions (pale blue) that have filamentous structure, resembling the surface 
morphology of some cells. The surface-exposed amine groups of N-terminal Ala-1 
(yellow stick) and Lys-8 (red stick) of the viral major coat proteins (blue for a single 
pVIII unit) are used for the Staudinger ligation with primary antibodies to yield 
microspheres covered with high-density antibodies. Protein figures were generated 
using VMD [94] based on PDB code 1IFJ. 
 
 
The viruses are comprised of five different kinds of structural proteins (pIII, 
pVI, pVII, pVIII, and pIX) that encase a single-stranded viral DNA. Among them, 
more than 2700 copies of the major coat protein pVIII serve for the assembly of 
filamentous structure with their ε-amino groups of Lys-8 and α-amino groups of N-
termini being exposed, each of which have been successfully modified with 
macromolecules using chemical conjugation [80, 95-97]. A minor coat protein pIII, 
three to five copies per virion, has been dominantly used for the display of peptides 
and proteins (Scheme 1) [55]. 
The filamentous morphology of the filamentous (fd) virus provides unique 
opportunity to construct bioinspired architectures because the virus has similar 
structural dimensions to many cellular threadlike structures that leverage various 
cellular functions. Furthermore, in biorecognition processes, such as ligand-receptor 
interactions, longer and flexible tethers and polyvalency have proved to be beneficial 
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[98-101]. Indeed, in biological systems, neuronal cells are rich in neurites and 
filopodia that maximize the cellular interactions by forming synapses [102]. 
Leukocytes, macrophages, and some epithelial cells are covered with microvilli that 
facilitate cellular movement, adhesion, endocytosis, and exocytosis [103]. Similarly, 
some bacterial cells represent pili that help cell–cell interactions essential for mating; 
others have fimbriae that aid adhesion [104, 105]. Based on these observations, we 
reasoned that the surface of gold microspheres, once modified with nanostructured 
filamentous virions, would have greater surface to volume ratio, mimicking 
biological architectures and thus allowing high degree of conjugation with functional 
molecules, such as antibodies. Such an increased ratio of antibody to biomarkers, 
together with three-dimensional gold-SAM protected surface of microspheres and 
microvilli-like long virus tethers, would provide improved performance compared 












3. Experimental methods 
 
3.1. Reagents 
Sulfo-N-hydroxysulfosuccinimide (Sulfo-NHS), sulfo-NHS-phosphine, NHS-
PEG12-azide, Streptavidin-coupled Dynabeads Myone T1 and 1-ethyl-3-[3-
dimethylaminopropyl] carbodiimide hydrochloride (EDC) were purchased from 
Thermo Scientific (Rockford, IL). Carboxyl-terminated hexa(ethylene glycol) 
undecane thiol (CMT002) was obtained from Nanoscience Instruments (Phoenix, 
AZ). Biotin-terminated daca(ethylene glycon) ethane thiol (41156-1095) was 
purchased from Polypure (Oslo, Norway). Carbenicillin (Carb) and isopropyl β -D-
1-thiogalactopyranoside (IPTG) were from Gold Biotechnology (St. Louis, MO). 
Streptavidin (SAV), bovine serum albumin (BSA), tetracycline (Tet), Tween-20, 
adenosine 5′-triphosphate (ATP), and cardiac troponin I (cTnI) were purchased from 
Sigma-Aldrich (St. Louis, MO). Plasmid pET21a-BirA was obtained from Addgene 
(Cambridge, MA). Magnetic gold microspheres (M-NG0501, Nomadien.com) were 
generated using proprietary methods including electroless plating of auric acids on 
proprietary magnetic poly(methyl methacrylate) (PMMA) beads (Nomadien.com) 
that were 15 μm in diameter. Nominal 10 μm diameter carboxylated polystyrene (PS) 
beads were from Polysciences (Warrington, PA). Phage vector, fd-tet with Sfi I and 
Not I cloning site in front of pIII, was kindly provided by Drs. Philipp Holliger and 
Chang-Hoon Nam. Rabbit polyclonal anti-fd (ab6188) and anti-cTnI (ab47003) 
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antibodies were purchased from Abcam (Cambridge, MA). Mouse monoclonal anti-
cTnI antibody [19C7] was from GeneTex (Irvine, CA). Chicken Alexa Fluor 594 
anti-mouse antibody (A21201), goat Alexa Fluor 610-R-Phycoerythrin (PE) anti-
rabbit antibody, Alexa Fluor 594 biocytin, streptavidin conjugated with horseradish 
peroxidase (streptavidin-HRP), biotin, and bacterial cell lines for protein expression 
and phage amplification were obtained from Invitrogen (Carlsbad, CA). Myoglobin, 
rabbit polyclonal anti-myoglobin antibody (70-MR13), and mouse monoclonal anti-
myoglobin antibody (10-M50A) were from Fitzgerald (North Acton, MA). 
 
3.2. Fluorescence microscopy 
Gold microspheres (~ 500) in phosphate buffered saline (PBS, 5 μL) were spotted 
on a glass slide. The fluorescence was monitored using Nikon Ti-E (Nikon, Japan) 
equipped with zyla sCMOS camera (Andor, Northern Ireland). At least thirty 
microspheres were chosen for the determination of mean fluorescence intensity (MFI) 
using NIS-Elements software version 4.2 (Nikon, Japan). 
 
3.3. Field-Emission Scanning Electron Microscopy (FE-SEM) 
The surface morphology of gold microspheres on a carbon tape was monitored using 
JSM 5410LV (JEOL, Japan) with 2 kV of acceleration voltage at the National 
Instrumentation Center for Environmental Management (NICEM), Seoul National 
University. To monitor the surface morphology of gold microspheres modified with 
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thiol SAM, streptavidin, and phage virions, Pt was sputtered using BAL-TEC SCD 
005 sputter coater at 15 mA for 100 s. 
 
3.4. N-SIM super resolution microscopy 
Fd-tet-APpIII phage virions on streptavidin coated microspheres were detected using 
rabbio anti-fd antibody and anti-rabbit alexa Fluor 488 antibody. Phage decorated 
microspheres in PBS (5 μm) were spotted on a glass slide. The fluorescence was 
monitored using N-SIM super resolution microscope (Nikon, Japan) at the 
Boimedical Imaging Center (BIM) of Seoul National University. 
 
3.5. Production of BirA 
His-tagged BirA was prepared according to the provider’s protocol with conditional 
modifications. Briefly, the pET21a- BirA plasmid was transformed into E. coli 
BL21(DE3)pLysS, plated on lysogeny broth (LB)-agar with Carb (100 μg/mL). A 
single colony was inoculated into LB-Carb media and was grown until the cell 
density reached mid-log phase when IPTG (1.0 mM) was added for induction. After 
overnight incubation at 37 °C, the cells were harvested, broken by sonication, and 
centrifuged. The supernatant was loaded onto Co-NTA column to purify His-tagged 
BirA. Typically, a small-scale pilot test was performed using seven individual 




3.6. Production of phages carrying biotinylation motif  
The two primers, AP-F (5′-CGG CCA TGG CAG GTC TGA ACG ACA TCT TCG 
AGG CTC AGA AAA TCG AAT GGC ACG AAG GCT CCG GTG C-3′) and AP-
R (5′- GGC CGC ACC GGA GCC TTC GTG CCA TTC GAT TTT CTG AGC CTC 
GAA GAT GTC GTT CAG ACC TGC CAT GGC CGG CT-3′), were annealed and 
ligated with fd-tet phage vector that had been digested with Sfi I and Not I. After the 
verification of the ligation by DNA sequencing, the phage vector was transformed 
into E. coli TG1 and grown in LB agar plate containing Tet (40 μg/mL) for 16 h at 
37 °C, the Next morning, a single colony was picked and inoculated into 3 mL of 
NZY liquid media with Tet (20 μg/mL) as a starter culture. For large-scale phage 
preparation, the starter culture was inoculated into NZY-Tet media (400 mL) and 
grown for 16 h at 37 °C with vigorous shaking. Phages were then purified by 
polyethylene glycol (PEG)/NaCl precipitation according to the standard protocols. 
 
3.7. Biotinylation of phages 
The purified phage virions (1013) were incubated with BirA (30 nM), biotin (100 
μM), and ATP (1 mM) in PBS-Mg (0.5 mL, pH 7.4 with 5 mM MgCl2 ) for 2 h at 
37 °C. The phages were then precipitated by PEG/NaCl two times and the residual 
PEG/NaCl molecules were removed by buffer exchange using Centricon (MWCO = 




3.8. Surface modifications of gold microspheres 
Gold microspheres (1 mg) was rotary incubated with thiol SAM molecules (1 mM) 
in 0.5 mL of ethanol for 16 h at 25°C. To the SAM-modified gold microspheres (5 
μg) was added EDC (2 mM) and NHS (5 mM) in 0.5 mL of MES buffer, pH 5.0 for 
30 min at 25 °C. The beads were then washed with PBS (1 mL, pH 7.4) three times, 
followed by the addition of streptavidin (0.5 mg) in PBS (50 μL). The streptavidin-
modified microspheres were treated with PBS-BT (PBS with 1% BSA, 0.1% Tween-
20, pH 7.4) for 30 min and the streptavidin loading was verified using biocytin-Alexa 
Fluor 594. 
 
3.9. Optimization of phage loading onto gold microspheres 
A range of biotinylated phage virions were rotary incubated with streptavidin-
modified gold microspheres (5 μg) in PBS-BT (50 μL) for 16 h at 25 °C. As a 
negative control, wild-type fd-tet virions were used. After washing three times with 
PBS, the beads were treated with anti-fd rabbit IgG (37 ng) in PBS (50 μL) for 1 h 
at 25 °C. After washing, the loading of phage virions were visualized by incubating 
with anti-rabbit Alexa Fluor 610-R-PE antibody (100 ng) in PBS (50 μL) for 1 h at 
25 °C, followed by the monitoring with a fluorescence microscope. 
 
3.10. Optimization of staudinger ligation 
Streptavidin-modified beads (5 μg) were incubated with varying amount of sulfo-
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NHS-phosphine in PBS (0.5 mL) for 1 h at 25 °C, which were used as a positive 
control. To build virus-immobilized beads, the streptavidin-modified beads were 
further incubated with 1.0 × 1010 of biotinylated phages in PBS-BT (50 μL) for 16 h 
at 25 °C, washed three times with PBS-BT and three times with PBS, followed by 
an incubation with a range of Sulfo-NHS-Phosphine in PBS (0.5 mL) for 1 h at 25 °C. 
For the Staudinger ligation, primary antibody from mouse (100 μg) was incubated 
with NHS-PEG12-azide (0.1 and 1.0 mM) in of PBS (0.1 mL) for 1 h at 25 °C, 
followed by overnight dialysis against PBS. The phosphine-treated streptavidin- and 
virus-gold microspheres (5 μg) were ligated with the azide-modified mouse antibody 
(0.5 μg) in PBS for 4 h at 37 °C. The resulting beads were then washed three times 
with PBS-BT, followed by the incubation with anti-mouse Alexa Fluor 594 antibody 
for the fluorescence microscopic analysis. As a negative control, anti-mouse Alexa 
Fluor 594 antibody was directly treated with streptavidin- and virus-beads without 
azide-modified antibody and the background signals, if any, were subtracted. 
 
3.11. Cardiac marker assays 
Initially, the streptavidin- and virus-gold microspheres (5 μg) were treated with 
sulfo-NHS-phosphine (0.5 mM) in PBS (0.5 mL) for 1 h at 25 °C, followed by the 
ligation with rabbit polyclonal anti-cTnI capture antibodies (0.5 μg) that had been 
incubated with NHS-PEG12-azide (100 μM) in PBS (50 μL) for 4 h at 37 °C. The 
resulting beads were then washed three times with PBS-BT and were mixed with 
cTnI (0.02, 0.2, 2, and 10 ng/mL) or myoglobin (0.02, 0.2, 2, 10, 40, and 100 ng/mL) 
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in PBS (0.5 mL) for 1 h at 25 °C. For the detection of cTnI in human serum, PBS 
was replaced with cTnI-spiked human serum (0.02, 0.2, 2, and 10 ng/mL in 0.5 mL). 
The beads were then washed, incubated with mouse monoclonal anti-cTnI detection 
antibody [19C7] in PBS (500 ng, 50 μL) for 1 hr at 25 °C, and visualized with anti-
mouse Alexa Fluor 594 antibody (500 ng). For the determination of background 












4. Results and Discussion 
 
4.1. Characterization of magnetic gold microshells 
Beads that are used in suspension arrays for bio-analysis are of low density and most 
of them use polymer microspheres, which are amenable to surface modification. 
However, these beads are not free from non-specific adsorption, which is a problem 
not only because it leads to adsorption of non-specific species into the microsphere 
surface, but also because of the introduction of these species into the polymer 
microsphere core. Therefore, in this study, we used gold microshells from Nomadien 
Corp. (www.nomadien.com), which consist of a thin gold layer that forms a metal 
barrier that blocks contact between the polymer core and external solution 
fundamentally while easily facilitating surface modification. Iron oxide was 
introduced into the poly(methyl methacrylate) (PMMA) surface to make the beads 
magnetic, and finally a gold layer was added using electroless plating (Figure 3a). 
The gold layer was approximately 200 nm thick, as verified by TEM (Figure. 3c), 







Figure 3. (a) SEM image of iron oxide embedded 15 μm magnetic gold microshells. 
TEM images of magnetic gold microshells (b) and (c). As shown in (c), the thin gold 







4.1.1. Testing the physical and chemical stability of gold microshells 
To measure the physical and chemical stability of the gold microshells, a 5 μg gold 
microshell was added to ethanol, dimethyl sulfoxide, N,N-dimethylformamide or 
1,4-dioxane solution. This was followed by sonication for 30 minutes and incubation 





Figure 4. Solvent test of gold microspheres. SEM images of gold microshells that 
were put into (a) PBS buffer, (b) ethanol, (c) dimethyl sulfoxide, (d) N,N-
dimethylformamide, or (e) 1,4-dioxane, followed by 30 minutes of sonication and a 





As shown in Figure 4, separation of the gold layer was observed as a swelling 
of the polymer microsphere in the organic solution. Separation of the gold layer was 
also observed when sonication was performed for more than 30 min. We did not 
observe cracking of the gold layer in the water and ethanol solution (Figure 4a-b). 
Thus, we confirmed that the gold layer is stable in an ethanol solution and remain 
stables even after up to three minutes of sonication. 
Next, we prepared SAM-protected gold microspheres using carboxyl-
terminated hexa(ethylene glycol) undecane thiol, followed by protein conjugation 
using 1-ethyl-3-(3-dimethylaminopropyl)-1-carbodiimide hydrochloride (EDC) and 
N-hydroxysuccinimide (NHS). The gold-layered microspheres were stable in 
ethanol for 16 h, enough time for SAM formation. The bead system facilitated 
chemical conjugation of protein on the SAM-modified gold microspheres using 
EDC-NHS in that the unreacted excessive EDC and NHS could be easily washed 
out. When gold microshell powder was added to the solution, the gold-gold affinity 
increased, resulting in aggregation (Figure 5a). However, because the SAM-
protected gold microshells have a high affinity for gold-thiol, they formed single 
beads (Figure 5b). The SAM-protected gold microshells were well dispersed in the 







Figure 5. (a) Optical image of the gold microshell before the SAMs were formed (b) 
Optical image of the gold microshell after the SAMs were formed (c) Dispersion 
state in the solution after the SAMs were formed (d) Image at 30 seconds after a 
magnet was placed beside the tube.  
 
 
To investigate the effect of temperature on SAM formation, SAM-modified 
gold microshells were incubated for 24 hours at either 4 °C or 25 °C and then 
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incubated with Alexa 594 conjugated biocytin at 4 °C, 25 °C or 40 °C. As shown in 
Figure 6, the fluorescence values for all samples were not significantly different 
within the error range. This result indicates that there was no desorption of SAM 
molecules at either 4 °C or 25 °C and there was no effect of temperature on 




Figure 6.  Verification of the stability of SAM-modified gold microshells. SAM-
protected gold microshells were incubated in phosphate-buffered saline (PBS) buffer 
at (a) 4 °C or (b) 25 °C for 24 hours. Each of (a) and (b) samples was incubated at 
4 °C , 25 °C , 40 °C for 24 hours and then treated with streptavidin and biocytin-
alexa594 for 1 hour at 25 °C to observe fluorescence. Biocytin-Alexa Fluor 594 dye 





4.1.2. Protein immobilization of gold microshells 
Having verified the stability of the thiol SAMs-treated gold microshells, we wanted 
to determine whether the protein could be incorporated into them. After activating 
the carboxyl-terminated gold microshells using EDC/NHS, the primary antibody 
was covalently attached and fluorescence was observed using an alexa488 
conjugated secondary antibody (Figure 8a). As shown in Figure 7c, green 





Figure 7. (a) Schematic representation of antibody immobilization on carboxyl-
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terminated gold microshells. After the primary antibody was attached to the surface 
of the gold microshells using EDC/NHS, the reaction was observed via fluorescence 
with an alexa488 conjugated secondary antibody. (b) DIC image. (c) Fluorescence 
image. 
To optimize protein immobilization on the gold microshells, we tested different 
numbers of gold microshells, antibody concentrations, working volumes, and 
reaction times. Full-length IgG antibodies have a molecular weight of 150 kDa and 
a size of 3 nm × 15 nm × 15 nm, and we assumed their area as 2 nm × 4 nm. Given 
the three-dimensional curvature of the microspheres, the degree of freedom of 
polyethylene glycol and the size of a single chain fixed at the surface, we estimated 
that 5 μg of 15 μm sized gold microshells would require 24 ng of antibody. The 
following conditions were fixed: 5 μg gold microshells, 500 μL working volume, 1 
h reaction time, and 2 μg secondary antibody. Only the amount of primary antibody 
was changed, and the degree of protein attachment was determined by the level of 
fluorescence (Figure 8a). A fluorescence value for the ratio of experimental value to 
theoretical value of the antibody was determined (Figure 8c), and with the use of 
approximately more than 20 times the amount of antibody, saturated fluorescence 
was found such that 500 ng used with 5 μg of gold microshells was sufficient. Thus, 
results from this experiment indicate that when proteins were fixed and secondary 






Figure 8. Optimization of antibody loading on gold microshells. (a) Schematic 
representation of antibody immobilization on thiol SAM-decorated gold microshells. 
(b) DIC and fluorescence images with different amounts of primary antibody, and a 
fixed amount of secondary antibody. (c) Fluorescence intensity according to the ratio 





Scheme 2. Schematic representation of streptavidin immobilization on gold 
microshells to determine the quenching effect. (b) and (d) are a control experiment 
after pretreatment with free biotin. (a) and (b) are pretreatments without albumin.  
 
 
Next, we evaluated streptavidin conjugation using biocytin-Alexa Fluor 594 
and biocytin-Alexa Fluor 488 (Scheme 2). When the beads were pre-treated with 
free biotin, no fluorescence was observed after incubation with fluorescent biocytin 
(Figure 9b and d). In contrast, we observed strong fluorescence signals when the 
beads were directly incubated with the fluorescent biocytin (Figure 9 Lower panel a, 
c). Unexpectedly, no green fluorescence was observed following incubation with 
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biocytin-Alexa Fluor488 (Figure 9 Upper panels a, c). This could be because the 
green fluorescence was quenched by the gold because there is some overlap between 
the maximum absorption wavelength of the absorption spectrum in the gold visible 
light region and the green region. Thus, we repeated the experiments only using red 
based fluorescence (biocytin-Alexa 594) and were able to observe fluorescence on 
the beads (Figure 9). In addition, in bio-analysis experiments, and in particular those 
involving blood, it is possible that proteins in the serum, such as albumin, could be 
a problem when using the polymer microspheres. However, we showed that there 
was no significant difference in fluorescence values following pretreatment with 






Figure 9. Results of streptavidin immobilization on gold microshells. In (a) and (c), 
experiments using biocytin-Alexa 488 (upper panels) did not show fluorescence due 
to quenching whereas biocytin-Alexa 594 (lower panels) showed strong 






4.1.3. Sandwich immunoassay of antibody-decorated gold microshells 
Using antibody-decorated gold microshells fixed directly with SAM molecules, a 
spike test of cardiac troponin I was conducted in human serum. A polyclonal 
antibody was covalently attached to the gold microshell using EDC/NHS and a 
sandwich-type immunoassay was performed after detecting a biomarker from the 
human serum (Scheme 3). For the control experiments, a carboxyl-terminated 
polymer microsphere was used and conditions without a biomarker or without a 
monoclonal antibody were compared to determine the level of fluorescence caused 









Figure 10. Detection of cardiac troponin I in human serum. 
 
 
We verified that the mean fluorescence intensity (MFI) was approximately 150 
for the gold microshells when 100 nm/mL cardiac troponin I was spiked in human 
serum. For polymer microspheres, high background fluorescence of 70 MFI was 
measured. This value was similar to that of a control sample in the absence of cardiac 
troponin I due to non-specific adsorption of secondary antibody. Gold microshells 
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in the absence of cardiac troponin I had a MFI value of approximately 5, which 
indicated significantly low non-specific adsorption. We inferred that this was due to 
the effect of the polyethylene glycol in the thiol SAM molecule and a thin gold layer 
that forms a metal barrier and blocks contact with the polymer core. Our colleague, 
S. R. Kwon, discovered how to prevent non-specific adsorption effectively using the 
same magnetic gold microshell and PEG-thiol SAM molecules that we used through 
MALDI analysis [106]. S. R. Kwon et al. shows the MALDI-TOF mass spectra for 
commercial polymer microspheres and for the magnetic gold microshells used in our 
experiments. A human serum albumin peak of non-specific adsorption was detected 
at 33 and 66 kDa , but was not detected with magnetic gold microshells. The 
detection ability of Myoglobin, which is a target biomarker, showed that the 
magnetic gold microshells had the best result. Based on the above results, 
polyethylene glycol and the metal barrier are both effective at suppressing non-
specific adsorption. 
 
4.2. Preparation and characterization of engineered phage virions 
To prepare microshells covered with threadlike nanostructured surface, we 
employed fd-tet phage virus that has intriguing morphology similar to cellular 
microvilli-like edifice. A 14-mer bacterial biotin acceptor peptide (AP), 
GLNDIFEAQKIEWHE [107], was introduced using SfiI and NotI cloning sites in 






Figure 11. (a) Phage vector map, fd-tet with SfiI and NotI cloning site in front of pIII. 
(b) Wild-type fd-tet and AP-representing fd-tet-APpIII virions (1013) were treated 
with BirA, followed by western blot visualized using streptavidin-HRP. (c) The two 
primer, SfiI-Avitag-NotI-F and SfiI-Avitag-NotI-R, were annealed and ligated with 
fd-tet phage vector (a) that had been digested with SfiI and NotI. 
 
 
Since the ε-amino group of Lys, a specific biotinylation site within the AP tag, 
is vulnerable to chemical modification by NHS for the subsequent Staudinger 
ligation, we tried in vivo biotinylation of phages by endogenous biotin ligase BirA 
that recognize AP in bacterial cells [107]. The degree of in vivo biotinylation, 
however, was minute, making us to purify BirA and biotinylate the virions in vitro 
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[109]. When we incubated AP-containing phage (fd-tet-APpIII) with BirA, distinct 
bands (~60 kDa) appeared in a western blot using streptavidin-HRP (Figure 11b) and 






Figure 12. TEM image of PEG/NaCl-purified fd-tet-APpIII phage after 2% uranyl 





4.3 Evaluation and optimization of virus-decorated gold 
microshells 
We then briefly evaluated the loading of virions on streptavidin-gold microspheres 
and found saturated fluorescence signals using 1.0 × 1010 virions and 5 μg of 
streptavidin-gold microspheres (Figure 13). Given that the apparent diameter of 
terminal N1-N2 domain of pIII is ~6 nm and the tail part of the fd virus is composed 
of three to five copies of pIII [110], one virion may be ensconced in an area of ~8.5 
× 10-17 - 1.4 × 10-16 m2. Since 5 μg of gold microspheres corresponds to ~1,000 beads, 
the total surface area of the beads is ~7 × 10-7 m2 on which ~5-8 × 109 of virions can 
be accommodated without gaps in theory. 
 
Figure 13. BirA-treated fd-tet (upper panel) and fd-tet-APpIII (lower panel) phage 
virions (1.0 × 1010) on streptavidin-SAM gold microspheres were detected using 
(a) Alexa Fluor®  610 Succinimidyl Esters, (b) rabbit anti-fd antibody and anti-





Figure 14. Optimization of surface modifications of gold microspheres with 
streptavidin and phage virions. Various amount of biotinylated phage virions were 




Indeed, when we titrated the loading of virions on the microspheres, the 
fluorescence intensity began to plateau from 1.0 × 1010 virions near the theoretical 
value (Figure 14). Thus, we used 1.0 × 1010 virions to maximize antibody loading 


































4.4 Visualization of virus-decorated gold microshells 
We next compared the surfaces of gold microspheres before and after the phage 
immobilization. Figure 15a and b are the FE-SEM images of bare gold microspheres 
that reveal gold granules layered on the surface of microspheres. After thiol SAM 
formation, gold surface maintained the overall roughness similar to the bare gold 
surface (Figure 15c). By contrast, streptavidin-modified surface exhibited tiny 
pimples, believed to be Pt-coated streptavidin, added on the gold granular blocks 
(Figure 15d and Figure 16a). Furthermore, in the case of virus-modified surface, we 
could clearly identify the virion fibers on the streptavidin layer with the increased 
thicknesses of 10~15 nm due to the sputtered Pt (Figure 15e and Figure 16b). The 
virion strands appeared to lie down because of the dry conditions and Pt sputtering 






Figure 15. (a) SEM image of bare magnetic gold microspheres (scale bar = 10 μm). 
(b) Magnified image of gold microspheres reveals the morphology of gold layer 
(scale bar = 2 μm). Pt-sputtered surface morphology of the beads that had been 
modified with carboxyl-terminated hexa(ethylene glycol) undecane thiol SAM (c), 
then conjugated with streptavidin (d), and finally with pIII-biotinylated fd-tet phage 







Figure 16. (a) SEM images of independent areas of streptavidin-modified gold 
microshells with Pt sputtering. (b) SEM images of independent areas of streptavidin-




The presence of virus on the streptavidin-decorated gold microshells was 
verified via FE-SEM imaging, however the actual location of the virus in the solution 
was not known. To determine this, we used Alexa Fluor®  488 Succinimidyl ester, 
which is an amine-reactive dye and introduced fluorescence to the primary amine of 
the protein fixed at the bead in order to visualize the location of the virus in the 
solution. In contrast to streptavidin-coated beads in the absence of virus, the virus-
decorated beads were well established within the three-dimensional space (Figure 
17). As such, fixation using a virus rather than fixing an antibody directly onto the 
bead will increase the availability of the antibody and ultimately increase the 
frequency of ligand-receptor interactions. 
 
 
Figure 17. 3D N-SIM super resolution image from a 100 nm Z-stack step size and 
0.1 reconstruction factor. w/o phage (a) and w/ phage (b) (scale bar = 1 μm) at 1 
μm streptavidin-coated microsphere. 
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4.5 Optimization of the Staudinger ligation 
Staudinger ligation, an extended version of classical Staudinger reaction, has been 
rediscovered by Saxon and Bertozzi [111]. Among several bioconjugation 
techniques, the Staudinger ligation has garnered much interest in that it has highly 
chemoselective and bio-orthogonal conjugation mechanism (Scheme 4). 
Consequently, the Staudinger ligation has been deployed not only to label glycans, 
lipids, nucleic acids, proteins, and cell surface, but also to manufacture glycopeptides, 
microarrays, and biopolymers. To keep the intact filamentous structure of the virions 
on microspheres, conjugation reactions should be devoid of intra- and inter-
molecular crosslinking of the virions, while not interfering with a directional binding 
of virion tips to microspheres. To that end, we selectively biotinylated pIII parts for 
the orientation-controlled immobilization of fd virions and thereby used the 
Staudinger ligation, a bioorthogonal and chemoselective crosslinking between azide 






Scheme 4ii. Schematic representation of the fabrication of bio-inspired virus-gold 
microsphere. (a) The Staudinger ligation (azide-phosphine conjugation) between 
phosphine-activated A and azide-labeled B. An aza-ylide intermediate (middle) 
converts to a stable covalent amide bond (right). (b) A thin layer of gold allow facile 
surface modifications by thiol SAM followed by chemical conjugation of 
streptavidin. The resulting streptavidin-modified microspheres are decorated with 
pIII-biotinylated phage virions that have filamentous structure, resembling the 
surface morphology of specific types of cells. The surface-exposed anime groups of 
N-termini of the viral major coat proteins are conjugated with phosphine and mixed 
with azide-modified primary antibodies to yield microspheres covered with high-
density antibodies via bioorthogonal Staudinger ligation (figures shown cross-
sectional area of virions layer and not drawn to scale). 
                                           
ii Dr. Inseong Hwang contributed to this scheme. 
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We then optimized antibody labeling with either amine-reactive NHS-PEG12-
Azide or Sulfo-NHS-Phosphine. In our experimental conditions, antibody 
precipitated after incubation with Sulfo-NHS-Phosphine probably because of the 
increased hydrophobicity stems from the phenyl groups of phosphine. On the 
contrary, no antibody precipitate was found with NHS-PEG12-Azide, and no visible 
changes of streptavidin- and virus-beads were observed after labeling with Sulfo-
NHS-Phosphine; streptavidin is already fixed on the beads, allowing no further 
aggregation, and phages are rich in surface charges that negate the effect of increased 
hydrophobicity. After ligation of the azide-modified primary antibody and the 
phosphine-modified beads, we stained the beads with fluorochrome-labeled 




Figure 18. Optimization of Staudinger ligation using mouse antibody. (a) Gold 
microspheres, covered with streptavidin or phage virions, were treated with four 
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different concentrations of Sulfo-NHS-Phosphine, while mouse antibody were 
incubated with 0.1 mM and 1.0 mM NHS-PEG12-Azide. (b) streptavidin or phage-
covered gold microspheres were incubated with fixed concentration of phosphine 
(0.5 mM), while the concentration of azide varied. Anti-mouse Alexa Fluor 594 
antibody was used for the determination of mean fluorescence intensity (MFI). 
 
 
We found that the optimum concentration of phosphine was around 0.5 mM 
with 100 μM azide where, among others, the virus-tethered beads exhibited the 
highest fluorescence intensity (Figure 18a). The efficiency of antibody loading 
decreased at higher concentration of azide (1.0 mM) probably because of the limited 
access of secondary antibody to buried epitopes of the primary antibody. Lower 
amount of azide (20 μM) did not seem to push efficacious Staudinger ligation (Figure 
18b). However, we cannot rule out the possibility that the lower the level of azide 
modification, the better the antibody activity. 
 
4.6 Sandwich immunoassay of cardiac biomarkers 
To demonstrate the effect of long virus threads, after antibody loading we compared 
the biomimetic virus-beads with streptavidin-coated beads in terms of antibody 






Figure 19. Sandwich immunoassay profiles (top) and representative fluorescence 
images of each functionalized microspheres corresponding to the w/o initial and final 
concentrations (bottom) tested for cardiac marker proteins. A range of cTnI in PBS 
(a), myoglobin in PBS (b), and cTnI in serum (c) were detected using virus- and 






We focused on the low range of cTnI and relatively higher range of myoglobin 
concentrations on the basis of clinical applications [112]. In immunoassays using 
cTnI- and myoglobin-spiked PBS, virus-decorated gold microspheres showed 
markedly enhanced signals compared to streptavidin-modified gold microspheres 
(Figure 19a and b). We could detect as low as 0.2 ng/mL of cTnI and myoglobin 
using virus-beads. The signals from streptavidin-beads lingered with the background 
until the concentration reached 2.0 ng/mL of cTnI and myoglobin. The effect of 
virions was more dramatic in the higher range of cTnI concentration with up to 9-
fold increase in fluorescence signal at 10 ng/mL, while the effect of virions on 
myoglobin showed 2-fold increase within the concentration range tested. The 
difference in fold increase may originate from the intrinsic variances of antigens, 
such as size, structure, and binding constant to primary antibodies. Note that the 
difference in assay performance is greater than the one in the antibody loading 
between the streptavidin- and virus-beads (see Figure 19). Furthermore, the effect of 
viral fibers stands out when the amount of captured antigens, and thus the detection 
antibodies in sandwich assay, is limiting. Therefore, the enhanced sensitivity of the 
virus-beads may be ascribed to the greater amount of antibody and the long and 
flexible virus filaments that increase receptor-ligand interactions. 
The preventive role of SAM-gold layer for nonspecific adsorption was marked 
in immunoassays using serum samples that were spiked with cTnI. Interestingly, 
both the virus- and streptavidin-beads detected as low as 20 pg/mL of cTnI (Figure 
19c), while the streptavidin-beads exhibited partial improvement at higher 
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concentration of cTnI (10 ng/mL) with two fold lower sensitivity than the virus-
beads. Importantly, we observed concentration-dependent increase of fluorescence 
signals at lower range of cTnI only in the case of virus-beads. By contrast, typical 
carboxylated polystyrene (PS) beads, on which antibodies were conjugated with 
EDC-NHS chemistry, failed to produce any signals throughout the range tested in 
serum, although the beads were able to detect cTnI in PBS (Figure 20). 
 
 
Figure 20. Immunoassay of cTnI in PBS buffer (10 ng/mL) using 10 μm-diameter 
polystyrene beads whose surfaces were modified with an anti-cTnI antibody using 
EDC/NHS chemistry. (a) DIC image. (b) Fluorescence image.  
 
 
The reason why the sensitivity for cTnI in serum should increase remains 
obscure, although the results suggest that the dense antibodies on phage tentacles 
and the SAM-gold protection layer synergistically enhance the sensitivity for the 
lower range of marker proteins. 
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5. Conclusion and Perspective 
 
In cellular systems, threadlike protruding structures have been evolved to sustain 
efficacious cellular functions, such as cellular uptake of small- and large molecules, 
cellular adhesions to biological and non-biological matrices, cell-cell interactions, 
and ligand-receptor interactions. Inspired by the cellular morphology and by the 
additive effect of long tethers on receptor-ligand interactions, we decorated SAM-
protected gold microspheres with filamentous virions that mimic microvilli-like 
biological architectures. The SAM-protected virus-gold microspheres showed 
extremely low non-specific bindings, enhanced capacity of antibody loading, and 
superior performance in analyte-solid surface interactions when compared with bare 
polymer beads and non-viral streptavidin-gold beads. The gold-protected and virus-
tethered microbeads that resemble biological architectures will open up new 
possibilities for developing biocompatible and bio-inspired solid surfaces for the 
improved analyte-solid surface interactions. The microsphere, which is the key to 
the multiplex suspension array, can be replaced with the virus-decorated gold 
microshells we developed. This is applicable to the entire field of in-vitro diagnoses 
and feasible for point-of-care testing (POCT) in combination with microfluidics. 
Also, since gold microshells with a thin gold layer themselves conduct electricity, 
they could be used in electrical connections in printed circuit boards or connections 









Cell-solid surface interaction: 
Purified synaptic cell adhesion molecules for 



















A neuron is the main cell constituting the nervous system. Unlike other cells, it can 
transfer electrical signals, and can be classified into various types according to 
location and function. A typical neuron is composed of the cell body, called a soma, 
the signal receptors, called dendrites, and the main channel of signal transmission, 
called an axon. In the nervous system, neuron-to-neuron communication occurs by 
electrical or chemical signals passing through the neuron junctions (synapses). A 
typical synapse consists of a connection between the axon of one neuron and a 
dendrite or soma of another. The electrical signals are transmitted by the presynaptic 
axons and are transformed into chemical signals (neurotransmitters) in synapses 
where the probability of the transmission of the electrical signals to postsynaptic 
dendrites is determined by the types of the neurotransmitters. Excitatory synapses 
allow postsynaptic transmission of electrical signals, inhibitory synapses block 
postsynaptic transmission of the signals. 
In-depth analysis of the signal transmissions between the axon and synapse 
reveals that they are ultimately a local movement of chemical species, and such 
changes in their electrochemical potential allow external stimulation or 
measurements of signals within the cell. Currently, in most studies, excluding the 
patch clamp method, neuronal cells are simply developed on or near a solid electrode 
surface to receive cellular signals. 
E.G. Gray elucidated the structure of a synapse using an electron microscope in 
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1959 [113]. Synapses are ~1 μm in diameter with an intercellular space called 
synaptic cleft, which is ~20 nm wide, and their formation requires mutual pairing 
between cell adhesion molecules (CAMs). Synaptic CAMs are proteins localized on 
the cell surface that adhere to the pre- and post- synaptic terminals and increase the 
mechanical stabilization of the synapse, while modulating its structure and function. 
Generally, synaptic CAMs consist of 3 domains: the intracellular domain that 
interacts with intracellular scaffold proteins, the transmembrane domain, and an 
extracellular domain that interacts with other Synaptic CAMs. Several families of 
Synaptic CAMs have been discovered [114], including neuroligins (NLs), neurexins 
(Nrxs), Slit and Trk-like family (Slitrks), netrin-G ligand proteins (NGLs), leucine-
rich repeat transmembrane neuronal proteins (LRRTMs), neural cell adhesion 
molecules (NCAM), L1-cell adhesion molecules (L1-CAMs), synaptic adhesion-
like molecules (SALMs), etc (Table 4). 
Most attempts in the formation of artificial synapses started from the year 2000 
when seminal experiments were reported on stable synaptic junctions between non-
neuronal cells expressing synaptic CAMs and cultured neuronal cells [115, 116, 121]. 
Recently, the purified synaptic CAMs were immobilized on a solid surface to induce 









NLs post Nrxs, PSD-95 Excitatory synapse formation (NL1) 
Slitrks post PTPδ Inhibitory synapse formation 
(Slitrk3) 
NGLs post PTPσ, etc Maintain excitatory synaptic current 
(NGL3) 
LRRTMs post Nrxs Excitatory synapse formation 
Nrxs pre NLs, LRRTMs Induce post-synaptic differentiation 
(β-Nrx) 
L1-CAMs pre - Decrease of inhibitory synaptic 
response (L1) 
SALMs both NMDAR, etc Control of excitatory synapse 
maturation (SALM2) 
pre, pre-synaptic; post, post-synaptic; both, pre- and post-synaptic; PSD-95, post-





Among other synaptic CAMs, NLs and Nrxs are the most studied proteins; rats 
and mice have three genes encoding NLs, whereas humans have five. Previously in 
1995, Südhof et al. first purified NL1 using affinity chromatography with 
immobilized Nrx-1β [119], and the complete paired structure of NL1 and Nrx-1β 
was revealed in 2007 [120]. Scheiffele et al expressed NLs in HEK-293 cells, co-
cultured them with neuronal cells [121], and discovered that NL1 triggers pre-
synaptic development. Similarly, Südhof et al. transfected NL1 derivatives into COS 
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cells and showed that this induced the formation of an artificial synapse [122]. 
Furthermore, Groves and coworkers immobilized a glycosylphosphatidylinositol 
(GPI)-linked NL1 ectodomain on silica microbeads covered with supported lipid 
bilayer (SLB) membrane, and confirmed the synaptogenic activity of the GPI-
anchored NL1 ectodomain [118]. On the other hand, Colman group used poly-D-
lysine (PDK)–coated polymer beads to induce the formation of artificial synapses 
without using synaptic CAMs [123]. Recently, research is being actively conducted 
on various synaptic CAMs and induced artificial synapses, but the function and 








Unlike the detection of delocalized analytes in solutions, the detection of 
extremely local neuronal signals (e.g., electrical signal or neurotransmitter) needs 
sophisticated regulation of distances between an electrode surface and cells. Studies 
have so far only stochastically localized the cells on a solid surface, which causes a 
loss in sensitivity, selectivity, and reproducibility. If we allow the cells to meet 
electrodes through the synaptic connections, we not only ensure the reproducible 
physical geometry of the cell-electrode interfaces, but also have the possibility to 
measure neurotransmitters otherwise impossible (Scheme 5). Therefore, it is 
expected that the synaptic CAMs, which were developed to induce artificial synapses 
on a solid surface, will allow us to consistently position the neuronal cells evenly, 
thereby providing reproducible and selective signal exchanges. Furthermore, the 
induced artificial synapses using synaptic CAMs will ultimately provide the 
foundation for the systematic study of interactions between the solid surface and the 
cells, as well as the understanding of the information processes in neural networks. 
   To understand and mimic neuronal network behavior, the ability to monitor, and 
thus distinguish between, the excitatory and inhibitory signals is essential. In 
biological systems, excitatory and inhibitory synapses are determined by synaptic 
CAMs [124, 125]. Notably, chemical conjugation of NL1 on polystyrene beads, 
despite their capability of adhering to Nrx-expressing cells, failed to induce 
presynaptic differentiation, suggesting that NL1 requires fluidic lipid bilayer 
environment for its activity [117]. As a consequence, the use of synaptic CAMs such 
as NL1 to build artificial synapses has been blocked by the lipid membranes that 
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create a huge insulating barrier between neurons and the signal recording materials, 
e.g., electrodes. When it comes to direct recording of neuronal signals via artificial 
synapses induced by synaptic CAMs, an electrode is expected to act as a ‘fake’ 
postsynaptic bouton, and thus the requirement of lipid bilayer on the electrode is a 
significant challenge. NL isoforms (NL1, 3, and 4) are well-known to induce the 
formation of excitatory (glutamatergic) presynapses, while NL2 and recently found 
Slitrk3 inhibitory (GABAergic) presynpases [126-129]. As synaptic CAMs for 
inhibitory synapses are quite rare, unprecedented specificity to inhibitory synapses 
of Slitrk3 is of importance [130, 131]. 
Here, we demonstrate functional interactions of fluorescent and biotinylated 
synaptic CAMs with cultured hippocampal neurons, independent of SLB media. The 
fluorescence tag should aid in establishing stable cell lines, and thus mass production, 












2. Experimental Methods 
 
2.1. Materials 
Plasmids encoding cholinesterase-like domain (CLD) of neuroligin-1 (NL1) 
followed by GPI anchoring motif (pNICE-HA-H6-NL1-GPI) and full length NL1 
and NL2 (pNICE-HA-H6-NL1 and pNICE-HA-NL2) were a generous gift from 
Peter Scheiffele. A plasmid carrying EYFP-tagged full length NL1 (pNICE-YFP-
NL1) was a kind gift from Ann Marie Craig. A plasmid encoding full length Slitrk3, 
pGW1-Slitrk3, was a kind gift from Jaewon Ko. A plasmid expressing TagRFP-T 
(pcDNA3-TagRFP-T) was kindly provided by Roger Y. Tsien. BirA expressing 
plasmids pDisplay-BirA-ER (Addgene plasmid #20856) and pET21a-BirA 
(Addgene plasmid #20857) were provided by Alice Ting. pAd:CMV-rtTA-IRES-
BirA was a gift from William Pu (Addgene plasmid #31375).  
Carbenicillin (Carb) was from Gold Biotechnology (St. Louis, MO). 
Streptavidin, bovine serum albumin (BSA) (A3059), adenosine 5’-triphosphate 
(ATP), polyethyleneimine (Mw: 25,000), Kanamycin sulfate, and G418 (Geneticin) 
were from Sigma-Aldrich (St. Louis, MO). QIAprep Spin Miniprep, QIAGEN 
Plasmid Plus Midi, QIAquick Gel Extraction, Phusion DNA polymerase, and Ni–
NTA resin were obtained from Qiagen (Seoul, Korea). Restriction enzymes and T4 
ligase were obtained from New England Biolabs (Ipswich, MA). Alexa-labeled 
secondary antibodies, bacterial cell line DH10B, mammalian cell line HEK293-H, 
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HEK-293, streptavidin conjugated with horseradish peroxidase (streptavidin-HRP), 
Opti-MEM®  I Reduced Serum Medium, Biocytin-Alexa 594, D-biotin, and 
Dynabeads®  M-280 Streptavidin were obtained from Life Technologies (Invitrogen, 
Carlsbad, CA). Goat NL1 polyclonal antibody (sc-14084) was from Santa Cruz 
Biotechnology, Inc. (Santa Cruz, CA) 
 
2.2. Molecular biology 
2.2.1. Y-NL1-G 
pNICE-YFP-NL1 was cut by KpnI and NotI to remove the predicted O-glycosylation 
motif (OG), transmembrane domain (TMD), and cytosolic domain of NL1 was 
replaced by GPI linker from pNICE-HA-H6-NL1-GPI by cutting with the same 
enzymes, yielding pNICE-YFP-NL1-GPI. 
 
2.2.2. Y-NL1 
The GPI portion of the pNICE-YFP-NL1-GPI was replaced with GS-linker 
(PHLHNLDI639 GGGSGGGSEGGGSGGGSGGGSEGGGSGG) fused with a 14-
mer biotin acceptor peptide (AP or AviTag, GLNDIFEAQKIEWHE). First, pNICE-
YFP-NL1-GPI and the staggered PCR product (primers N38, N39, N40 and N41) 
were digested with KpnI and NotI and ligated together. To aid purification, His×8 
encoding primers, N43 and N44, were annealed and introduced in front of the YFP 





TagRFP-T was PCR amplified from the pcDNA3-TagRFP-T plasmid using primers 
N48 and N49, cut by PvuI and SalI, and ligated with pNICE-H8-YFP-NL1-AP that 
had been digested with the same restriction enzymes, resulting in pNICE-H8-RFP-
NL1-AP (encoding R-NL1).  
 
2.2.4. NL1-R 
First, we replaced the GPI tag of pNICE-HA-H6-NL1-GPI with a new GS linker 
containing additional cloning sites, PvuI and SalI, and AP tag 
(PHLHNLDI639GGGSGGGSEGGGSGGGSGGGSEG-RS(PvuI)GVD(SalI)-
(AP)). The GS linker was synthesized using primers N38, N39, N50 and N41 by 
staggered PCR, cut by KpnI and NotI, and ligated with pNICE-HA-H6-NL1-GPI 
that had been cut by KpnI and NotI, yielding pNICE-HA-H6-NL1-GS-PS-AP. The 
TagRFP-T PCR product obtained from primers N48 and N49 and pNICE-HA-H6-
NL1-GS-PS-AP were then digested with PvuI and SalI, followed by a ligation to 
give pNICE-HA-H6-NL1-H8-RFP-AP (encoding NL1-R). 
 
2.2.5. NL2-R 
NL2 was amplified from pNICE-HA-NL2 using primers N55 and N56. The GS 
linker was PCR amplified from pNICE-HA-H6-NL1-H8-RFP-AP using primers 
N103 and N104. The pNICE-HA-H6-NL1-H8-RFP-AP was but by BamH I and SalI 




Ectodomain of Slitrk3 was copied from pGW1-Slitrk3 using primers N83 and N74-
2 and cut by HindIII and KpnI. The GS linker fused with H8-RFP, 
GT(KpnI)GSGGGSEGGGSGGGSGGGSEG-RS(PvuI)-(H8-RFP)-VD(SalI)-(AP), 
was PCR copied from pNICE-HA-H6-NL1-H8-RFP-AP using N38-2 and N41 and 
cut by KpnI and NotI. The pNICE-HA-H6-NL1-GS-AP was cut by HindIII and NotI 
and served as a vector for three-piece ligation, finally giving pNICE-SL3-H8-RFP-
AP encoding SL3-R. To screen linker sequences, pNICE-SL3-H8-RFP-AP was 
cleaved by KpnI and PvuI where other linkers with various lengths were inserted. 
The active SL-R was obtained using annealed primers N106 and N107, yielding 
GT(KpnI)GSGGGSEGRS(PvuI)-(H8-RFP)-VD(SalI)-(AP). 
Bicistronic synaptic encoding of postsynaptic CAMs and BirA: To make a 
bicistronic expression vector that allows a simultaneous expression of BirA-ER with 
the postsynaptic CAMs, the internal ribosome entry site (IRES) followed by BirA-
ER gene was introduced (Figure 21). The pNICE-(HA-H6)-CAM-H8-RFP-AP 
(CAM = ectodomain of NL1, NL2, or Slitrk3) were cleaved by NotI to insert IRES-
BirA that was amplified from pAd:CMV-rtTA-IRES-BirA using primers N86 and 
N87 and cut by NotI, generating pNICE-CAM-RAP-BirA after ligation.   
Bacterial expression and purification of bacterial BirA biotin ligase was 
conducted using pET21a-BirA plasmid. The major primers used in this study are 




Table 5. Primers used for the generation of protein NL1-R. Sequences underlined 
are crossover area for the staggered PCR. 




N38-2_KpnI-GS-F ggcggt GGTACCGGCAGCGGCGGAGGCAGCGAGGG 
(35) 
N39_AP-2R      GCCCTCGCTGCCGCCTCCGCTGCCGCCTCCGCTGCC
TCCGCCCTCGCTGCCTCCGCCGCT (60) 




N50_AP-PvuI-SalI-3F     GCGGAGGCGGCAGCGAGGGCCGATCGGGTGTCGA
CGGCCTGAACGACATCTTCGAGGCCC (60) 
N43_H8-PvuI-F  CGCACCATCACCACCACCACCATCACCGAT (30) 





N48_EK-SalI-R   gccaccGTCGACCTTGTCGTCGTCGTCCTTGTACAGCT
CGTCCATGC (47) 
N55_NL2-BamHI-F GTGTGGTCCACAGG GGATCC (20) 













N104_SalI-AP-R CGAAGATGTCGTTCAGGCCG (20) 
N106_SL3-shortGS-F CGGCAGCGGCGGAGGCAGCGAGGGCCGAT (29) 





2.3. Stable cell lines 
For the initial screening of synaptogenic activity of NL1 ectodomains, 24 μg of each 
NL1-encoding plasmid DNA (pNICE-H8-YFP-NL1-AP, pNICE-H8-RFP-NL1-AP, 
and pNICE-HA-H6-NL1-H8-RFP-AP) was added to the 1.5 mL of Opti-MEM I 
Reduced Serum Media. Likewise, 60 μl of 1.0 mg/mL PEI solution was added to the 
1.5 mL of Opti-MEM solution. After 5 min incubation at 25 °C, the two solutions 
were mixed at room temperature for 30 min and added to HEK293 cells grown to 
~20% confluence in a culture dish of 10 cm diameter at 37 °C. The DMEM medium 
was replaced after 4 h incubation. After three days, the cells were treated with G418 
with final concentration of 0.8 mg/mL. The G418 treatment was repeated with fresh 
medium after two days. After two weeks, single colonies with brightest fluorescence 
signals were picked and seeded on a 24-well plate. Among them, the best fluorescent 
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colonies were repeatedly selected until only one colony was left and seeded on a 
culture dish of 10 cm diameter for the subsequent passage. The established stable 
cell line was kept in DMEM medium containing 100 μg/mL G418. 
 
2.4. Preparation of biotinylated synaptic CAMs 
Plasmid pDisplay-BirA-ER (24 μg) in 1.5 mL of Opti-MEM solution was mixed 
with 1.5 mL of Opti-MEM solution containing 60 μg of PEI for 20 min at 25 °C. The 
mixture was added to the established HEK293-H stable cell lines at ~20% confluence 
in a culture dish of 10 cm diameter. After 4 h incubation, the DMEM medium was 
replaced with a fresh one containing 100 μg/mL G418 and 10 μM biotin. The in vivo 
biotinylated synaptic CAM was allowed to secrete into culture medium for three 
days at 37 °C. Then, 10 mL of the medium was saved and the whole cells were 
transferred to a culture dish of 15 cm diameter and filled with 30 mL of DMEM 
containing 100 μg/mL G418 and 10 μM biotin. After another three days, the culture 
media were combined and subjected to column purification using 2 mL of Ni-NTA 
resin according to the manufacturer’s protocol. The three 1 mL elution fractions were 
subjected to fluorescence analysis using Synergy Mx fluorescence microplate reader 
(BioTek, Seoul, Korea). 
For in vitro biotinylation, the stable cell line was grown without BirA 
transfection. To the 1 mL of column elution fraction showing the highest 
fluorescence signal was added 5 mM MgCl2, 1 mM ATP, 0.1 mM biotin, and 30 nM 
BirA enzyme as final concentration and shake incubated for 2 h at 37 °C. The level 
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of in vivo and in vitro biotinylation was analysed via western blot using streptavidin-
HRP or using goat or mouse anti-NL1 antibody and HRP-conjugated secondary 
antibody. The purity of NL1 was analysed by SDS-PAGE with silver staining 
 
2.5. Immunocytochemistry 
Cells were fixed using formaldehyde (4%) for 25 min and rinsed three times with 
PBS (100 mM, pH 7.4). The cells were then incubated in blocking solution (PBS 
containing 4% BSA and 0.1% Triton X-100) for 30 min, followed by incubation in 
primary antibodies diluted in TBS (Tris-buffered saline, pH 7.4) containing BSA 
(0.5%) and Triton X-100 (0.1%) overnight at 4°C. The samples were then washed 
three times with TBS and the fluorescent secondary antibodies were applied for 1 h 
at room temperature in TBS containing BSA (0.5%). The samples were washed 
again three times with TBS and once with DDW, and stored in VECTASHIED 
Mounting Medium with DAPI at -80°C until microscopic examination. Fluorescence 
images were taken with a Zeiss LSM710 confocal laser scanning microscope 
equipped with ZEN 2009 software at the National Center for Inter-university 








3. Results and Discussion 
 
3.1. Construction of labelled NL1 ectodomains 
To generate type-specific artificial dendrites, ectodomains of NL1 (48-639), NL2 
(15-614), and Slitrk3 (28-649) were exerpted from their full sequences (Scheme 5). 
NL1 ectodomain was determined by the crystal structure of NL1/Nrx-1β complex 
that reveals Leu636 as the end of the α-helix required for NL1 dimerization [120, 
132]. Indeed, NL1 (46-638) was the minimum domain functionally secreted to the 
culture medium, whereas NL1 (46-626) and NL1 (46-633) were not [133]. 
Intriguingly, the functional GPI-anchored NL1 contains Leu48-Pro631 [117, 125, 
134], lacking several C-terminal amino acids required for the formation of α-helix 
bundle. Since the GPI motif linked to NL1 (48-631) begins with KLLSATA that has 
high α-helical propensity [135], the overall dimeric structure of GPI-anchored NL1 
may have remained unaltered despite the absence of 631-638 helical residues. 
Ectodomain of NL2 (15-614) was determined by sequence homology with NL1. The 
border of Slitrk3 ectodomain was conservatively set further away from the C-
terminal Leu-rich repeat domain (LRR-CT), seven residues before the 






Scheme 6iii. (a) Schematic structure of artificial synapse displaying postsynaptic 
NL1 homodimer (NL1-R), NL2 homodimer (NL2-R), and Slitrk3 (SL3-R). The 
                                           
iii Dr. Inseong Hwang contributed to this scheme. 
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structures were modeled after NL1 (PDB ID, 3BIX) [120] and NL2 (PDB ID, 3BL8) 
[136], while the structure of Slitrk3 (27-627 residues) was predicted using Slitrk1 
(PDB ID, 4RCW)[137] as a template by the RaptorX server [138], showing two 
LRR1 and LRR2 domains. (b) Schematic structures of engineered synaptic CAMs 
used in this study in comparison to wild type NL1 (WT). (c) Predicted structure of 
NL1-R-Nrx1β complex. The C-terminal tagging module for ectodomain of 




To facilitate massive production, purification, quantification, and localization of 
the ectodomains as well as immobilization of the ectodomains on solid supports, we 
further engineered the NL1 ectodomain, seeking a general tagging module that can 
be applied to the other synaptic CAM molecules. On the basis of previous studies 
showing that both N-terminally YFP-tagged full-length NL1 [139] and 
glycosylphosphatidylinositol (GPI)-linked NL1 ectodomain [117, 125, 129] are able 
to instruct excitatory presynaptic differentiation, we first generated N-terminally 
YFP-tagged and C-terminally GPI-anchored NL1 (Y-NL1-GPI). Unfortunately, the 
purification yield of the Y-NL1-GPI was extremely low, making us replace the GPI-
anchoring motif with AP, a biotin acceptor peptide [140], yielding C-terminally 
biotinylated Y-NL1. To prevent possible dimerization of YFP, we replaced YFP with 
TagRFP-T, a photostable monomeric red fluorescence protein (RFP) [141], to 
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generate R-NL1. We also moved the fluorescence tag from N-terminus to C-
terminus of NL1 ectodomain, while keeping the AP-tag at the ultimate C-terminal 
end of the engineered protein, yielding NL1-R.  
The in vivo biotinylation was further simplified by bicistronic expression of ER-




Figure 21iv. Genetic engineering of postsynaptic CAMs for facile mass production 
with in vivo biotinylation. SS, signal sequence; HA, hemagglutinin affinity tag; H6, 
hexa-His tag; GS, Gly-Ser rich linker; H8, octa-His tag; AP, biotin acceptor peptide; 
IRES, internal ribosome entry site. The SS, HA and H6 vary depending upon the 
type of the postsynaptic CAMs 
 
 
3.2. Generation of stable cell lines 
In order to make a stable cell line, the appropriate cell line and antibiotics must be 
selected. G418 is an antibiotic that is widely used to produce genetically engineered 
                                           
iv Dr. Inseong Hwang contributed to this figure. 
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proteins in mammalian cells, and HEK-293T cells are resistant to G418. Thus, we 
selected HEK-293H cells to perform the viability assay using G418. Figure 25 shows 
a DIC image that demonstrates viability over time in an 800 μg/ml concentration of 
G418. HEK-293H cells, which are adherent cells, grew well at first, while they were 




Figure 22. HEK-293H cell viability assay in 800 μg/ml G418 for (a) 0, (b), 1, (c) 2, 
(d) 3, (e) 5, (f) 7 days. 
 
 
Next, we optimized the conditions for transient transfection. As shown in Figure 
25, green fluorescent protein (GFP) was expressed in HEK-293H cells using either 
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calcium phosphate, lipofectamine 2000, or polyethyleneimine. The experimental 
results showed that the best transfection efficiency was obtained using 
polyethyleneimine (Figure 23c). The highest fluorescence levels were seen after 72 
hours, and this became reduced at 100 hours after transfection, due to GFP gene 
deletion. Thus, we added G418 to the culture media on the third day after transfection 




Figure 23. Optimization of transfection methods for a HEK-293H cell line. 
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Fluorescent images of GFP-transfected HEK-293H cells in three independent 
transfection experiments. (a) Calcium phosphate, (b) Lipofectamine 2000, (c) 
Polyethyleneimine. 
Figure 24 shows the transfection and selection results using the aforementioned 
conditions. It also shows the results of selection over time via fluorescence (Figure 
24a-c), and a single colony whose size was 0.5–1 mm (Figure 24d). We monitored 
expression, purification, and immobilization by tagging fluorescent proteins at the 
synaptic CAMs. It took at least 2 weeks to generate a stable cell line from G418-
treated HEK-293H cells. Two to four weeks after transfection, a selected cell had 




Figure 24. (a) 4, (b) 9 and (c) 12 days after transfection. (d) DIC image of a single 





After identifying a colony that was the appropriate size and that displayed bright 
fluorescence, it was picked using a micropipette on a fluorescence microscope and 
seeded into a 24-well plate. The established stable cell line was sub-cultured in the 
presence of 100 μg/mL G418 in a 10 cm-diameter culture dish (Figure 25). Each of 
the synaptic CAMs were well expressed, as verified by fluorescence. Synaptic 




Figure 25. Merged fluorescence and DIC images of stable cell lines in which 
synaptic CAMs of (a) Y-NL1-G, (b) Y-NL1, (c) R-NL1, (d) NL1-R, (e) NL2-R, and 
(f) SL3-R were expressed.  
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3.3. Purification of synaptic CAMs 
We employed biotin-streptavidin binding as a strategy to attach the synaptic CAMs 
to the solid surface. Two methods for binding biotin to synaptic CAMs are in vivo 
biotinylation, which expresses the BirA enzyme inside cells via transfection, and in 
vitro biotinylation, which uses the BirA enzyme in purified synaptic CAMs. The 
former purifies secreted biotin-conjugated synaptic CAMs by transfecting ER-
specific BirA plasmid into the stable cell line, while the latter purifies secreted 
synaptic CAMs in the stable cell line to perform additional biotinylation. Culture 
media containing synaptic CAMs were subjected to column purification using 2 mL 
of Ni-NTA resin according to the manufacturer’s protocol. Western blotting (Figure 
26) verified that the NL1 derivatives band was successfully purified.  
Quantification of the purified synaptic CAMs was verified by silver staining, 
western blot, and fluorescence intensity. A known amount of BSA was loaded and 
compared with a known volume of the synaptic CAMs elution fraction to yield the 
synaptic CAMs concentration (Figure 27). However, despite successful 
experimental results from in vivo and in vitro biotinylation of synaptic CAMs, those 
that were generated by in vitro biotinylation did not induce an artificial synapse. 
Thus, synaptic CAMs were attached to the streptavidin-coated dynabeads using the 
in vivo biotinylation method to induce an artificial synapse. Figure 30 shows the 
fluorescence image of NL1-R immobilized dynabeads. Since RFP is included, as 
shown in (Figure 30b), red fluorescence was observed in addition to the shape of the 
bead. However, RFP fluorescence was disappeared during the 
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Figure 26. Western blot profiles for the partially purified and labeled NL1s. The 
YFP-tagged NL1-GPI (Y-NL1-G) rarely appeared in the elution fraction despite its 
presence in the total cell lysate. When the GPI motif was replaced with AP, the YFP-
NL1-AP (Y-NL1) was secreted into the culture medium, and was retained in a Ni-
NTA resin. Both in vitro and in vivo biotinylation revealed biotinylated NL1 
regardless of the position of the fluorescence protein. Y-NL1-G was probed by anti-







Figure 27. Partially purified NL1-R was quantified using BSA standards. The 
biotinylated band was verified using western blot (right panel). The relationship 
between fluorescence intensity and concentration of NL1-R was determined to be 












Figure 28. Purified biotin tagged NL1-R was immobilized on streptavidin contained 
2.8 μm Dynabeads. (a) DIC image, (b) Fluorescence image. Since RFP is included, 




3.4. Identification of induced artificial synapse 
We then compared the synaptogenic activity of the engineered NL1 ectodomains by 
incubating them with DIV16 cultured neuronal cells for 24 h followed by 
immunocytochemistry (ICC) to identify immunopositive beads where synapsin I, a 
representative synaptic marker protein, was prominently clustered as a result of the 






Figure 29v. NL1-R induces artificial synapse independently of SLB membrane. 
NL1-R has the strongest synaptogenic activity streptavidin coated Dynabeads when 
incubated with DIV14 hippocampal neuron culture for 2 days. Synapsin I (Syn I) 
aggregation were induced by NL1-R on streptavidin coated Dynabeads. Scale bars 
= 10 μm.  
 
 
The dynabeads (Figure 29, left, upper images) to which each of the biotinylated 
NLs derivatives was fixed formed an artificial synapse by joining with randomly 
cultured hippocampal neurons. We found that although the N-terminally YFP-tagged 
NL1 was proven to have synaptogenic activity, biotin-tagged Y-NL1 was barely 
                                           
v Eun Joong Kim contributed to this experiment. 
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functional compared to NL1-R when immobilized on the dynabeads. On the other 
hand, we observed that strong fluorescence was emitted by the C-terminally RFP-
tagged NL1 on the microspheres and the most robust artificial synapse was induced. 
This indicated that the structural difference was important because synapses were 
induced through pairing with Nrxs even when the other components were the same. 
Furthermore, we separated and purified not only NL1 derivatives that induced an 
excitatory synapse but also NL2-R and SL3-R that induced an inhibitory synapse 
using the same experimental procedure, thereby verifying that an artificial synapse 
















4. Conclusion and Perspective 
 
We have demonstrated the feasibility of engineered synaptic CAMs for the induction 
of artificial synapses. The synaptic CAMs can easily be biotinylated in vivo, purified, 
and quantified from their initial production to the final assay steps. The NL1 
ectodomain allows C-terminal tagging for optical tracking and surface 
immobilization that dispenses with lipid bilayers for its synaptogenic activity. 
Removal of the lipid bilayer on inorganic substrates can greatly reduce the 
complexity and workload for establishing artificial synapses. This biased preference 
to a specific type of synapse induced by synaptic CAMs, if combined with other 
neuroengineering techniques such as micro- and nano-architectures for neural 
stimulation and recording, will provide unique possibilities for novel artificial neural 
interfaces. Moreover, this method will be used as the basis for studying the 
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고체상 추출은 시료를 전처리 하는 방법의 하나로 분석 분야에서는 복잡
한 미지시료에서 관심 종을 분석하기 위한 분리, 농축 및 정제의 수단으
로 사용되며, 최근에는 생체 모사 표면 공학을 통해 결합 친화성을 높이
고 민감도와 선택성을 증가시키려는 노력들이 진행되고 있다. 혈액과 세
포와 같은 복잡한 생체시료를 분석하기 위해서는 고체상 표면과 관심 종
과의 물리/화학적 상호작용이 매우 중요하며, 관심 분석물질이 고체표면
에 직접적으로 상호작용하는 유형과 세포와 같은 분석대상을 표면에 도
입하여 분비되는 물질을 관찰하는 유형으로 구분할 수 있다. 본 학위 논
문은 (i) 향상된 분석물질-고체표면 상호작용을 위한 생체 영감 표면 
수식화 와 (ii) 인공시냅스 유도와 생분석을 위한 신경 세포 부착 단백
질 정제의 응용사례를 보고했다. 
 
파트1. 분석물질-고체 표면 상호작용: 향상된 면역분석법을 위한 생체 
모사 건축물을 가진 바이러스로 꾸며진 자성 금 마이크로쉘 
 
섬사상 파지 바이러스는 세포의 기능을 높이는 많은 가늘고 긴 구조와 
유사한 구조적 차원들을 가지고 있다. 이 연구의 목적은 생물체의 시스
템을 닮은 바이러스와 마이크로 입자의 결합이며, 그렇게 함으로써 독특
한 형태에서 유래된 증가요소가 있다. 우리는 자기조립분자층을 형성하
기 위해 마이크로 쉘 위에 금 층을 형성하고 이는 스트렙타아비딘을 사
용한 화학조작과 비특이적 흡착을 방지하는데 도움이 된다. 파지 비리온
들은 스트렙타아비딘으로 개질 된 금 마이크로쉘에 선택적으로 결합하기 
위해 그들의 꼬리에 바이오틴이 결합되어 있다. 우리는 표면 대 부피 비
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율 증가로 인해 바이러스 개질 된 금 마이크로쉘 위에 고정되는 항체의 
양이 증가되는 것을 확인했다. 실제로 카디악 트로포닌I 와 마이오글로
빈 각각이 검출되는 민감도가 증가했다. 이 연구는 바이러스와 비 생체
물질의 결합이 정량분석 가능한 향상된 면역분석을 위한 생체모방 수단
이 될 가능성을 설명하고 있다. 
 
파트2. 세포-고체 표면 상호작용: 인공 시냅스 유도를 위한 신경 세포 
부착 물질 정제 
 
전통적인 신경 인터페이스는 오로지 신경세포와 비 생물체의 수동적인 
물리적 접촉에 의존한다. 하지만 뇌에서의 신경세포는 시·공간상의 특수
함이 정교하게 조절된 시냅스를 통해 의사소통 한다. 이 시점에 우리는 
새롭게 조작된 형광과 바이오틴이 붙어 정제, 정량, 추적, 무기 기질 위
에 고정이 가능하게 하는 시냅스 후 세포 부착 물질을 보고한다. 방향성
이 조절된 고정으로부터 유래된 지질 막 위의 시냅스 후 세포 부착 물질
의 독립성은 신경세포와 다양한 무기 고체 기질간에 인공 시냅스 형성에 
맞게 단백질의 기능성을 확장한다. 또한 세포와 고체 표면과의 상호작용
을 연구하기 위한 기초로 활용될 것이다. 
 
주요어: 골드 마이크로쉘, 서스펜션 어레이, 비특이적 흡착, 바이러스, 
인공 시냅스, 뉴로라이긴, 신경세포 접착물질 
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